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The herpes simplex virus type 1 immediate-early protein, ICP4, is the major transcriptional 
activator of viral early and late genes.  ICP4 has been shown to bind DNA and interact with 
components of the general transcription machinery to activate or repress viral transcription, 
depending on promoter context.  Microarray and northern blot analysis indicated that the 
abundance of the basal Pol II transcription machinery was significantly altered at late times of 
infection.  Because viral early and late genes have very different promoter architectures, the 
cellular requirements for ICP4-mediated activation of early and late genes may differ.  In testing 
this hypothesis using tk and gC as representative early and late promoters respectively, the 
general transcription factor TFIIA was found not to be required for ICP4 activation of the late gC 
promoter but was essential for activation of the early tk promoter.  An intact INR element was 
required for TFIIA to be dispensable for ICP4 activation of the gC promoter.  In the presence of 
TFIIA, ICP4 overcame the requirement for an intact INR on the gC promoter enhancing ICP4 
activation of an INR-mutated gC promoter. When examining the binding properties of TFIIA, 
ICP4 and TBP/TFIID on early, late, and INR-mutated late promoters, ICP4 could only 
effectively substitute for TFIIA in stabilizing the binding of TFIID to the TATA box of the late 
promoter containing a functional INR.  ICP4 required the additional activities of TFIIA to 
stabilize the binding of TFIID to the TATA box of an INR-mutated late promoter.  Additionally, 
microarray and northern blot analysis indicated that TFIIA expression was reduced at late times 
 iv
of infection.  The decrease in TFIIA expression during infection, the ability of ICP4 to substitute 
for TFIIA in stabilizing TFIID binding to an INR-containing late promoter, and its dispensability 
for activation of late but not early genes suggests a mechanism for the shutoff of early gene 
expression while allowing the continued expression of late genes. 
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1. INTRODUCTION 
 
 
 
1.1. HERPESVIRIDAE FAMILY 
 
Members of the Herpesviridae family consist of a group of DNA viruses composed of a 150 - 
200 nm diameter virion containing at least four components: a lipid bilayer envelope studded 
with 10 to 12 different surface glycoprotein projections, an amorphous protein layer known as 
the tegument containing viral proteins necessary for lytic infection, a 100 nm icosahedral 
nucleocapsid which houses the viral genome, and a DNA core organized into a toroidal form 
with no associated packaging proteins (15).  The viral genome consists of 120 - 200 kb of linear 
double stranded DNA encoding 60 – 120 genes.  Members of this family replicate in the nucleus 
of a wide range of vertebrate hosts: including humans, horses, cattle, mice, pigs, chickens, 
turtles, lizards, fish, as well as in some invertebrates (167).  Eight varieties have been isolated in 
humans that include herpes simplex virus 1 and 2 (HSV-1, HSV-2), varicella-zoster virus (VZV), 
human cytomegalovirus (HCMV or HHV-5), Epstein-Barr virus (EBV or HHV-4), human 
herpesvirus 6 and 7, and Kaposi’s sarcoma herpesvirus (HHV-8).  
Members of the herpesviridae family are further classified into three subfamilies: the 
alpha-, beta- and gamma-herpesviruses, based on tissue tropism, host range, duration of the 
reproductive life cycle and behavior under tissue culture conditions in the laboratory (reviewed 
in 168).  Alpha-herpesviruses have a variable host range, a relatively short reproductive life 
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 cycle, visible cytopathic effects (CPE), and are neurotropic, establishing latency primarily in the 
sensory nerve ganglia.  Members of this subfamily include Herpes simplex virus type 1 and 2, 
the primary agents of recurrent facial and genital herpetic lesions, and Varicella-zoster virus 
(VZV), the causative agent of chicken pox and shingles.  Members of the beta-herpesviruses are 
lymphotropic, establishing latency in secretory glands, lymphoreticular cells and kidneys.  These 
have a more restricted host range, a longer reproductive cycle than alpha-herpesviruses, and 
infected cells frequently become enlarged (cytomegalo).  Members of this subfamily include 
Human cytomegalovirus (HCMV or HHV-5), which causes infections in newborns and the 
immunocompromised, and Human herpesvirus 6 and 7 (HHV-6 and -7), which has been linked 
to mild early childhood diseases.  Gamma-herpesviruses are also lymphotropic, specific for 
either T- or B-lymphocytes.  Members of this subfamily include the causative agent of infectious 
mononucleosis, Epstein-Barr virus (EBV or HHV-4), and the recently described Kaposi’s 
sarcoma herpesvirus (KSHV-8 or HHV-8), which has been linked to human cancers. 
 
 
1.2. HSV PATHOGENESIS  
 
Of the eight known human herpesviruses, herpes simplex virus type 1 (HSV-1) is the most 
extensively investigated.  It is transmitted through close personal contact of susceptible 
oropharaynx or genital epithelia with infectious active virus.  Under certain conditions, HSV can 
also infect the eyes resulting in ocular herpes or other facial regions resulting in herpes keratitis 
(161).  It can also infect the central nervous system leading to herpes encephalitis (191).  During 
primary productive infection HSV undergoes DNA replication and amplification in susceptible 
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 surface cells of the oral or genital mucosa.  Viral progeny are produced eventually leading to cell 
lysis and subsequent infection of neighboring cells.  Skin lesions that result from inflammation 
and cell death at the site of infection are commonly termed as cold sores, fever blisters or genital 
herpes lesions.  From the initial site of infection, viral progeny gain access to innervating sensory 
neurons and travel via retrograde transport through the axons to the neuronal cell bodies in the 
sensory ganglia, such as the trigeminal ganglion or dorsal root ganglia (33).  In the neuronal 
nucleus, the virus either replicates or establishes latency (reviewed in 186).  The spread of virus 
from these neurons to adjacent or synaptically-linked neurons results in transneuronal infection 
and may be one method that results in viral encephalitis (114, 192, 193, 215). 
During latency, little to no viral gene expression occurs except for the latency-associated 
transcript (LAT) (30) the function of which is currently under debate.  Since neurons lack MHC 
class II expression and MHC class I expression is low, CD8+ cytotoxic and CD4+ helper T cells 
do not target these cells (159).  Thus viral genomes persist in these neurons in an inactive histone 
associated episomal state for the lifetime of the host, with little fear of elimination by the 
immune system.  Upon conditions of stress, such as fever, UV light or physical or emotional 
stress, or immunosuppression, the virus can reactivate (reviewed in 186).  Once reactivated, the 
virus undergoes de novo protein synthesis and replication.  Viral progeny travel via anterograde 
transport back to the primary site of infection where it re-establishes a productive infection 
known as recurrent infection (reviewed in 198). 
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 1.3. HSV PRODUCTIVE LIFE CYCLE 
 
HSV infection begins with attachment of a virus particle to the surface of a permissive cell.  This 
involves recognition of cell surface receptors by virion glycoproteins (reviewed in 183).  The 
initial association occurs between heparan sulfate proteoglycans on the cell surface and the viral 
glycoprotein gC.  This is followed by specific interaction of viral glycoprotein gD with one or 
more of several cell surface receptors.  These include HVEM (herpesvirus entry mediators), a 
member of the TNF receptor family, and nectin-1 (HveC) and nectin-2 (HveB), receptors that are 
related to the immunoglobulin superfamily.  Binding of gD to one of these receptors triggers 
viral fusion, which requires the action of other glycoproteins, gB and a heterodimeric complex of 
gH-gL (in addition to gD and the gD receptor).  Following fusion of the viral envelope with the 
host cell plasma membrane, the glycoprotein-studded envelope remains at the surface of the 
plasma membrane, while the de-enveloped virus particle enters the cell and is targeted via the 
intracellular transport machinery to nuclear envelope pores (182).  After reaching the nuclear 
pores the viral DNA is released into the nucleoplasm.   
In the nucleus, the regulated and ordered gene expression of the HSV genome occurs.  
Each gene has its own promoter that utilizes the host RNA polymerase II transcription machinery 
to transcribe its genes at the expense of cellular gene expression (184).  HSV genes are expressed 
in three major kinetic classes: immediate-early (IE, α), early (E, β) and late (L, γ) (reviewed in 
199, 203).  Immediate-early genes are the first viral genes expressed due to the potent 
transactivation potential of the virion-associated protein VP16.  Viral mRNA is processed in the 
nucleus, transported and translated in the cytoplasm.  IE genes mainly encode nuclear bound 
proteins that are involved in transcriptional and post-transcriptional regulation of the rest of the 
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 viral genome.  Once IE proteins are produced and localized in the nucleus, early genes are 
expressed.  Early gene products are involved in DNA synthesis and viral replication.  Viral 
replication takes place when sufficient quantities of early proteins are present.  Viral replication 
was originally thought to occur via a rolling circle mechanism from circularized genomic DNA 
(reviewed in 14) however recent evidence indicates that genomic DNA does not circularize upon 
entry into the nucleus (98) suggesting that replication occurs from a linear DNA template.  Once 
DNA replication is underway, late genes are expressed encoding proteins that make up the 
structural components of the virion such as glycoproteins, capsid components, and tegument 
proteins.   
Empty procapsids are assembled in the nucleus and packaged with linear double-stranded 
viral DNA.  Packaged nucleocapsids bud into the inner leaflet of the nuclear envelope.  Fusion 
then occurs with the outer nuclear leaflet, releasing the nucleocapsid into the cytoplasm where it 
acquires tegument proteins.  Nucleocaspid with tegument is doubly enveloped by host 
membranes containing Golgi modified glycoproteins.  Once matured, virions exit the cell 
through fusion of the outer host membrane containing the enveloped viruses with the surface of 
the plasma membrane (reviewed in 134). 
During infection many viral induced cellular changes occur to prime the cell for viral 
gene expression and replication.  One rapidly occurring change upon initial infection is the 
shutoff of host protein synthesis.  This is due to the functions of the virion host shutoff protein 
(vhs), a tegument protein encoded by the UL41 gene.  Once released into the newly infected cell, 
vhs increases the rate of mRNA degradation in the cytoplasm contributing to the global 
suppression of cellular protein synthesis (reviewed in 179).  vhs is an mRNA-specific RNase that 
disrupts preexisting polyribosomes, and triggers rapid degradation of all mRNAs.  It exhibits a 
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 high degree of specificity, as it apparently targets only mRNAs, while sparing other cytoplasmic 
RNA species.  However, vhs is not selective to cellular over viral mRNAs, as both are affected.  
This results in a global increase in mRNA instability of even viral messages.  The increased 
mRNA instability accelerates the kinetics of viral gene expression by promoting the transition 
between each successive phase of viral gene expression favoring the HSV life cycle.   
 
 
1.4. HSV GENOME CONFIGURATION 
 
The HSV genome is approximately 152 kb of linear double stranded DNA (108) with a base 
composition of 67% G + C (130), packaged in the form of a torus in the virion (67).  It consists 
of a covalently linked long (L) and short (S) region, each containing unique sequences (Fig. 1) 
(reviewed in 129).  The unique L (UL) region is 108 kb and encodes at least 56 distinct genes that 
are involved in DNA replication, viral gene expression or that make up the structural 
components of the virion.  The unique S (US) region is 13 kb and contains 12 open reading 
frames encoding glycoproteins.  These unique sequences are each flanked by inverted repeats, 
the L (RL) and S (RS) repeat.  The 9 kb L repeats (RL) encode the immediate-early protein ICP0 
and the latency-associated transcript, while the 6.6 kb short repeats (RS) encode the immediate-
early protein ICP4.  Genes located in the inverted repeat regions are thus present in two copies.  
The repeats of the L component are designated ab and b’a’ and those of the S component are 
designated a’c’ and ca.  The structure of the a sequence is highly conserved but the number of a 
sequences at the junction between the L and S region and at the L terminus is variable from 
strain to strain.  Depending on the number of a sequences at the junction of the two unique 
6 
 regions and at the L terminus, the genome sizes of various isolates of a particular virus can vary 
up to 10 kb (197).  The long and short regions can invert relative to one another causing the 
genome to exist as a mixture of four isomers in equimolar proportions (42).  The a sequences at 
the ends of the linear molecule are important in both concatemerization and in packaging the 
DNA in the virion.  There are three origins of replication.  The oriL is located in the middle of the 
UL region, while the oriS is located in the RS and is present in two copies.  
 
Figure 1.  Schematic representation of the DNA sequence arrangement of the HSV genome. 
The HSV genome is divided into unique long (UL) and unique short (US) regions, composed of 108 kb and 13 kb of 
DNA, respectively.  These unique sequences are separated by inverted repeats RL and RS (depicted as arrows) that 
are 9 kb and 6.6 kb, respectively.  The RL is composed of a and b sequences and the RS is composed of a and c 
sequences.  A varying number of a sequences are found at the terminus of UL and the junction of UL and US.  Only 
one copy of a sequence is found at the US terminus.  Each a’, b’ and c’ represents an inverted sequence of a, b, and c 
sequences.    
 
 
The HSV genome encodes at least 80 open reading frames that are distributed throughout 
the genome on both strands without many intervening sequences (reviewed in 129).  The 
structure of HSV genes closely resembles that of cellular genes in that each viral gene contains a 
promoter, a 3’ UTR, an open reading frame and a polyadenylation signal (8).  However, one of 
the major distinctions between HSV and cellular genes is the lack of introns in the majority of 
HSV genes.  Of the more than 80 viral transcripts expressed during infection, only four contain 
introns, with three of these four being immediate-early transcripts (155).  The lack of introns 
serves to benefit the virus in mechanisms that will be discussed further below.  
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1.5. CASCADE OF HSV GENE EXPRESSION  
 
During the lytic cycle of HSV-1 infection, synthesis of viral gene products occurs in three 
temporally regulated phases, immediate-early, early, and late (also termed α or IE, β  or E, and γ 
or L respectively)  (Fig. 2) (reviewed in 158, 199, 203).  The pattern of viral protein synthesis is 
determined by the pattern of viral gene transcription and the level of viral mRNA accumulated in 
infected cells (102).  Viral gene products regulate the cascade of gene expression through 
positive or negative regulation of their own genes or of genes in different kinetic classes.  
Expression of individual genes is regulated mainly at the level of transcription initiation (199, 
200). Each gene contains its own promoter.  Each promoter contains a TATA box that is 
recognized by the cellular TATA binding protein (TBP), allowing transcription of all viral genes 
by the host RNA Pol II transcription machinery (6, 36).  Although HSV promoter structures 
contain many similarities to cellular RNA Pol II promoters, each class of genes differs with 
respect to the timing of expression and promoter architecture.  Two major factors controlling 
transcription of HSV genes are the presence of both viral and cellular specific promoter elements 
associated with each of the three gene classes, and the trans-acting viral and cellular transcription 
factors that recognize these elements.  The mechanism of sequential viral gene expression has 
been suggested to be due to class specific differences in promoter architecture.  These are critical 
in determining the ability to nucleate the assembly of stable preinitiation complexes at various 
phases of infection mediating class-specific transcription kinetics.  Additionally, DNA 
replication also has a significant influence on viral gene expression (reviewed in 199, 203).  The 
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 onset of DNA replication significantly reduces early gene expression while it is required for the 
initiation of late gene expression. 
Expression of all three classes of genes ultimately leads to virus production, eventual 
death of the infected cell, virion release and spread to neighboring cells.  In permissive cells, this 
entire process takes approximately 18 to 20 hours (Fig. 2) (93). 
 
Figure 2.  Cascade of HSV gene expression and viral progeny production in permissive cells. 
The expression of immediate-early genes encoding viral transcriptional and post-transcriptional regulatory proteins, 
peaks expression at approximately 3 hour post infection and subsequently slowly decreases.  Early gene expression 
encoding genes involved in nucleotide metabolism and DNA synthesis, progressively increases at 4 hours post 
infection, peaks at 6 hours and decreases thereafter.  DNA replication can be detected at approximately 4 hours post 
infection.  Late gene expression encoding structural components of the virus, steadily increases at 6 hours post 
infection and peaks at approximately 13 hours post infection.  At around 8 hours post infection infectious viral 
progeny can be identified and the amount of infectious virus increases exponentially to 16 hours post infection when 
1000 plaque-forming units per cell can be detected.  
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1.5.1. Regulation of immediate-early gene expression 
 
Within the first hour of infection, immediate-early genes are transcribed, constituting the first 
phase of viral gene expression (Fig. 2) (93).  Immediate early promoters are the most complex, 
with binding sites for both viral and cellular specific factors located upstream of the TATA box 
(Fig. 3).  Expression of IE genes is mainly regulated at the level of transcription initiation 
through TAATGARAAT motifs found exclusively on IE promoters upstream of the TATA box.  
TAATGARAAT motifs are recognized specifically by the viral tegument-associated protein, 
VP16 (reviewed in 7, 89, 207).  Upon release into newly infected cells, VP16 translocates to the 
nucleus where it associates with host cellular factors Oct1 and HCF.  This viral and cellular 
protein complex then binds to TAATGARAAT motifs to trigger activation of IE genes.  The 
activation domain of VP16 interacts directly with the general transcription factors TFIID, TFIIB 
and TFIIA to recruit and stabilize their interactions with IE promoters leading to the subsequent 
recruitment of the remaining general transcription factors to these promoter (reviewed in 65).  In 
addition to VP16 binding sites, these promoters contain cellular cis-acting elements located 
upstream of the TATA box, such as CAAT box elements and Sp1 binding sites (101).  These 
serve as binding sites for cellular specific factors that also interact with one or more of the 
general transcription factors.  These factors synergize with the activities of VP16 to recruit and 
stabilize the cellular transcription machinery on IE promoters that in turn activate transcription.  
It is due to these VP16 specific binding sites that IE genes are rapidly expressed upon initial 
infection without any prior viral protein synthesis. Five immediate early products are produced: 
10 
 ICP0, ICP4, ICP22, ICP27 and ICP47 (28, 93, 153).  These proteins play critical regulatory roles 
in the progression of the lytic cycle.  In the absence of competent immediate early proteins, 
particularly ICP4 and ICP27, minimal early proteins are produced, DNA replication is halted, 
and the lytic cycle does not progress (44, 51, 128, 169). 
 Peak synthesis of IE gene products occurs 3 hours post infection (hpi) and their 
expression significantly decreases thereafter (93).  One mechanism for the attenuation of IE 
genes is through the actions of the immediate-early protein ICP4, which is largely responsible for 
the attenuation of its own expression (71, 166).  ICP4 in conjunction with the general 
transcription factors TBP and TFIIB binds directly to high affinity ICP4 DNA binding sites 
located near the start site of transcription (80, 113, 181).  Binding of ICP4 in a tri-partite 
complex to these high affinity sites is thought to block RNA Pol II from initiating transcription 
thus decreasing its expression.  In the absence of ICP4, IE genes are over-expressed and E genes 
are under-expressed (31, 44, 51, 156, 176). 
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 Figure 3.  Representation of immediate-early, early, leaky-late and true late HSV promoters.  
The general arrangement and composition of cis-acting regulatory elements for the indicated promoters are shown.  
One element common to all HSV promoters is a TATA box that is the binding site for the general transcription 
factor TFIID resulting in their expression by the host cellular transcription machinery. Aside from a TATA box the 
number and arrangement of cis-acting elements varies among each class of promoters. 
 
1.5.2. Regulation of early gene expression 
 
Early (E) gene products are involved in DNA synthesis and viral replication.  Expression of these 
genes are strictly dependent on the presence of competent IE proteins particularly the immediate-
early protein ICP4, which serves as the major transcriptional activator of early and late gene 
expression (45, 58, 72, 74, 142).  While early promoters still retain many of the same cellular cis-
acting sequences as those found on immediate-early promoters, these promoters are devoid of 
viral cis-acting sequences, particularly the TAATGARAT motifs present on immediate early 
promoters (Fig. 3).  Early genes are not expressed immediately upon viral entry due to the lack 
of VP16 specific elements.  However, E promoters like IE promoters contain a TATA box and 
still retain many of the same binding sites for upstream cellular factors.  Despite the reduction in 
the number of cis-acting sequences in comparison to immediate-early promoters, these sites play 
an important role in the activation of early genes.  Common cis-acting sequences found on early 
promoters are Sp1 and CAAT-box sites, that can be found on early promoters in multiple copies 
(29, 132).  Although there are no ICP4 specific sites on early promoters, ICP4 is required for 
efficient expression of early genes.  Through non-specific DNA binding, ICP4 can highly 
activate transcription of early promoters (96, 202).  In the absence of either ICP4 or cellular 
activators, early genes are not efficiently activated or expressed.  The cellular transcription factor 
Sp1 has been shown to play an important role in early gene transcription (101).  The functions of 
12 
 Sp1 and other cellular transcription factors work in concert with ICP4 to recruit and stabilize the 
cellular transcription machinery on early gene promoters.  
Expression of early genes precedes viral DNA synthesis and reaches maximum levels 
between 4 and 6 hours post infection (Fig. 2) (93).  With the onset of replication, early gene 
expression rapidly declines and is selectively repressed after viral replication.  Inhibitors that 
block replication, allow for the continued high level expression of early genes (117), suggesting 
that the shutoff of early gene expression is somehow linked to viral DNA replication (reviewed 
in 199, 203).  However, the exact mechanisms for early gene attenuation are not well understood.  
One possible mechanism is through modulation of the activities of transcription factors during 
infection that are required for early gene expression, as has been shown to occur with the 
transcription factor Sp1.  Under normal conditions, Sp1 is a common cellular transcription factor 
that binds specifically to Sp1 sites and participates in the recruitment of the transcription 
machinery via interactions with co-activators of transcription, such as the ‘Mediator’ complex 
and the TBP-associated factor 110 (TAF110) of TFIID (68, 103, 139, 190). However, 
approximately 6 hours into HSV infection, Sp1 is quantitatively phosphorylated, coinciding with 
the time early gene expression declines (109).  Although phosphorylation does not alter the 
abundance or the DNA binding ability of Sp1, it correlates with a decrease in the activation of 
the viral early gene, thymidine kinase.  Additionally, Sp1 harvested from infected cells is less 
active than Sp1 from uninfected cells suggesting that phosphorylation of Sp1 interferes with its 
ability to activate transcription.  Thus the phosphorylation of Sp1 during HSV infection may be 
one of the mechanisms that contribute to the reduced levels of IE and E gene expression late in 
infection.   
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 Another mechanism of early gene attenuation that will be discussed in further detail in 
Chapter 3 and 4 is through alterations in the expression of components of the general 
transcription machinery.  We show that the general transcription factor TFIIA, is required for 
ICP4-mediated activation of a representative early gene, yet during infection the expression of 
TFIIA decreases, suggesting that late in infection TFIIA is no longer available to participate in 
early gene expression and may also contribute to attenuation of early genes.    
 
1.5.3. Regulation of late gene expression 
 
The late or γ genes are last set of genes expressed, peaking at 13 hpi (Fig. 2) (93).  Late genes 
products form the structural components of the virion such as glycoproteins, capsid, and 
tegument proteins necessary for virion formation.  Late gene expression is highly dependent on 
viral DNA replication as well as the activities of the immediate-early gene products, particularly 
ICP4 (51, 202). Late genes can be classified as either leaky-late (γ1) or true-late (γ2) depending 
on their requirement for DNA replication (reviewed in 199, 203).  Leaky-late genes are those 
that have a loose requirement for replication and whose products can be detected late in the lytic 
cycle, during the decline of early gene expression, but present prior to the onset of DNA 
replication (216).  Moreover, these genes are expressed even in the presence of DNA replication 
inhibitors suggesting some other mechanism of regulation other than the requirement for 
replication.  True late genes, however, are strictly dependent on viral DNA replication and are 
halted for gene expression in the presence of DNA replication inhibitors.  Several mechanisms 
have been suggested to explain the dependence on viral replication for late-gene expression.  
These include differences in promoter strength and architecture, the presence of transcription 
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 inhibitors that are titrated out following replication, conformational changes of the genome after 
viral replication, and differences in polyadenylation sites.  
Examination of late gene promoters reveals that in contrast to immediate-early and early 
promoters which contain numerous upstream cis-activating sequences, most late promoters are 
deficient for sequences upstream of the TATA box (Fig. 3) (reviewed in 200, 203).  While leaky-
late promoters still contain one or more cis-acting site for cellular transcription factors that may 
work to activate transcription from these promoters prior to replication, most leaky-late and all 
true late promoters lack any influential upstream activating elements.  In general the sequences 
upstream of the TATA box do not play a critical role in late gene expression as they can be 
mutated or deleted without detrimental effect on the ability of ICP4 to activate transcription from 
these promoters.  Rather for most leaky-late and all true late promoters, the sequences located 
downstream of the TATA box, such as the initiator (INR) and the downstream activating 
sequence (DAS), are critical for activation (82, 83, 185, 205).  True late promoters generally 
consist of a TATA box and an INR.  The INR is a common feature of many cellular promoters 
with a loose consensus sequence, YYA+1N(T/A) YY (where Y is pyrimidine and N is any 
nucleotide) (178).  It can direct the specific initiation of transcription by itself or synergistically 
with other promoter elements (177).  We have shown that the INR is essential for ICP4-mediated 
activation of a representative true-late promoter, glycoprotein C (79, 110).  The nucleotide 
contacts important for INR function are important for optimal induction by ICP4.  Although the 
gC promoter contains a consensus DAS motif in addition to a TATA box and INR, only 
mutations in the INR severely compromise the ability of ICP4 to activate transcription of this 
promoter.  Furthermore, in vivo analysis of wild-type and INR-mutated forms of the gC promoter 
showed that INR function is critical for high levels of gC mRNA accumulation late in infection 
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 (110).  These results suggest that the INR and TATA box are the only cis-acting elements that 
are absolutely essential for ICP4 activation of the late gC gene during viral infection. 
1.6. PARTICIPATION OF VIRAL PROTEINS IN TRANSCRIPTION 
 
The two virion-associated proteins, VP16 and vhs, that participate in viral gene expression very 
early during infection, have been discussed above.  Four of the five IE proteins also play critical 
roles in the regulation of HSV gene expression (22, 44).  ICP4, ICP0, ICP27 and ICP22 are all 
nuclear phosphoproteins that possess transcriptional and post-transcriptional regulatory activities 
(1).  The activities of these proteins prepare the cell for and participate in the efficient cascade of 
viral gene expression, DNA replication, and the production of progeny virus (22, 44, 128).   
 
1.6.1. ICP27 
 
ICP27 is a 63 kDa nuclear phosphoprotein that is an essential regulatory protein in all 
experimental systems.  It is a multifunctional protein that has been shown to regulate viral and 
cellular mRNA processing events, as well as modulate the activities of ICP4 and ICP0 (133, 
162).  ICP27 is found to co-localize with ICP4 within HSV replication compartments in infected 
and transfected cells.  ICP27 is required for the transcription of a subset of viral early and has 
been implicated in the switch from early to late gene expression during viral replication (128).  
ICP27 facilitates DNA synthesis by stimulating the expression of early genes, which in turn 
allows for efficient DNA replication and late gene expression.  ICP27 is essential for productive 
infection due to its multitude of regulatory effects both at the transcriptional and post-
transcriptional levels.  Evidence for these include effects on polyadenylation site selection, 3’ 
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 RNA processing, and splicing of mRNA transcripts (reviewed in 170). Transcription and pre-
mRNA processing are coordinated events and ICP27 has been shown to interact with the RNA 
Pol II holoenzyme (217) and bind to many of the proteins involved in splicing.  By binding to 
splicing proteins, ICP27 prevents their participation in the splicing process.  Because only three 
of the four HSV transcripts that are spliced are IE genes, these genes are transcribed maximally 
before splicing is inhibited.  In addition to interfering with splicing, ICP27 has been shown to 
stabilize labile 3’ ends of mRNA, induce nuclear retention of cellular intron-containing 
transcripts while shuttling viral intronless transcripts out of the nucleus, and regulate distribution 
of host small nuclear ribonucleoproteins (snRNPs).  
 
1.6.2. ICP0 
 
Although not essential for growth in tissue culture, ICP0 deficient HSV is impaired for growth at 
low multiplicities of infection.  ICP0 is a 110 kDa nuclear phosphoprotein that plays a key role 
during lytic infections, as well as in the establishment of and reactivation from latency (reviewed 
in 57, 84).  ICP0, known as a promiscuous transactivator, will activate a broad range of viral and 
cellular promoters in transient assays and no promoter specific sequence is required for its 
activity.  ICP0 has been found to elevate levels of viral gene expression and growth in tissue 
culture and in the trigeminal ganglia of mice.  It has been shown to stimulate expression of all 
three temporal classes of viral genes (22) by increasing the rates of transcription.  Although it 
can activate transcription alone, ICP0 in conjunction with ICP4 will synergistically activate 
transcription to a level that exceeds activation with either protein alone.   
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 Early in infection, ICP0 localizes to the nucleus where it co-localizes with pre-existing 
nuclear sub-structures known as ND10 (or promyelocytic leukemia (PML) nuclear domain 
bodies) and within hours disrupts these domains by inducing the degradation of a number of 
ND10 components such as PML and Sp100 (59).  ICP0 has also been found to co-localize at the 
centromeres of condensed chromosome disrupting these structures.  The ring finger domain of 
ICP0, which is a ubiquitin E3 ligase, is required for ND10 and centromere disruption (16).  ICP0 
is thought to activate transcription indirectly through the induced degradation of specific cellular 
targets found within ND10s, such as PML and Sp1, that may repress viral transcription 
(reviewed in 57). 
 
1.6.3. ICP22 
 
ICP22 is a 68 kDa nuclear protein that is not essential for viral growth in many cell types yet acts 
to promote efficient expression of late genes in a cell type dependent manner (171).  ICP22 in 
conjunction with UL13 have been shown to localize to replication compartments within infected 
cells and both are responsible for the altered phosphorylation of the carboxy-terminal domain of 
RNA polymerase II (121).  The significance of this modification to RNA Pol II is not clear since 
ICP22-deficient virus will replicate in some cells types without observable altered Pol II 
phosphorylation (121).  However, this modification is suggested to contribute to the shift in 
transcription from host to viral genes (121, 163, 164).  Additionally, ICP22 interacts with several 
cellular proteins including cell cycle regulated proteins (17).  ICP22 and the UL13 protein kinase 
mediate the stabilization of cdc2 while its cyclin partner, cyclin B, is simultaneously degraded 
(2).  Cdc2 binds the viral protein UL42 and this complex recruits the cellular factor 
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 topoisomerase IIa (3) to newly synthesized viral DNA.  This is thought to untangle concatemeric 
DNA which is suggested to ensure the optimal expression of a subset of late genes such as UL11, 
UL38 and UL41, post DNA-synthesis (4). 
 
 
 
 
1.6.4. ICP4 
 
The immediate-early protein ICP4 has both positive and negative regulatory effect on viral gene 
expression.  It is the major transcriptional activator of early and late genes (45, 58, 72, 74, 142) 
making it essential for productive lytic infection (51, 156).  
 
1.6.4.1. Location  
 
ICP4 can be detected in numerous discrete foci in the inner rim of the nucleus within 1 hour post 
infection.  Many of these ICP4 containing foci are observed to associate with ND10 structures 
containing ICP0 during the early stages of infection (61).  A proportion of these foci, containing 
one or more parental viral genomes, have been shown to develop into viral replication 
compartments later in infection.  Positioning of ICP4-containing nucleoprotein complexes to 
ND-10 bodies is thought to potentate viral replication.  It is these foci where not only replication 
but also transcription originates.  These ICP4 concentrated areas predominate throughout lytic 
infection where ICP4 and other co-localizing viral transcriptional modulators, such as ICP27 and 
ICP22 (60) exert their effect on viral gene expression. 
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1.6.4.2. Structure 
 
The ICP4 encoding gene, IE3, is located within the inverted repeats that flank the unique short 
region, resulting in two copies of the IE3 locus within the HSV genome (138). The ICP4 
polypeptide is a 1,298 amino acid protein with a corresponding molecular weight of 175 kDa on 
SDS-polyacrylamide gels (37).  However, in its natural state it exists as a highly phosphorylated 
350 kDa homodimer in the nucleus of infected cells that has the ability to dimerize on DNA (37, 
135, 137).  It appears as three electrophoretic species on SDS-PAGE (153) and as seven species 
on two-dimensional gels (1).  The fastest-migrating form seen on SDS gels accumulates in the 
cytoplasm, while the two slower-mobility species localize in the nucleus.  The observed 
differences in mobility are, in part, due to differences in phosphorylation patterns (63, 153, 204, 
208).  ICP4 is also subjected to other post-translational modifications including adenylation, 
guanylation and adenosine diphosphate (ADP) ribosylation (12, 13).  Of all these modifications, 
only phosphorylation has thus far demonstrated to affect the activity of ICP4 (10, 137, 149).  
ICP4 has been characterized as an elongated molecule as determined by gel filtration with a 
Stokes radius of approximately 90 Å (176).  It can be divided into several discrete regions, which 
are conserved among the ICP4 orthologs of related alpha-herpesviruses, including the 
pseudorabies virus IE180 (27), the varicella-zoster virus ORF62 protein (131) and the equine 
herpesvirus immediate-early protein.  These conserved regions of ICP4 include an N-terminal 
transactivation domain, a DNA binding and a nuclear localization domain and a C-terminal 
transactivation domain (Fig. 4) (47, 151, 172). 
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Figure 4.  Primary structure of ICP4. 
A comparison of ICP4 and its VZV ortholog ORF62 is indicated directly below the primary amino acid sequence 
with the white boxes specify regions of conservation.  Colored boxes directly below their location within the 
primary structure indicate functional regions and physical properties of ICP4.  
 
N-TERMINAL TRANSACTIVATION DOMAIN 
 
The N-terminal transactivation domain of ICP4 lies between amino acids 142 - 210 and contains 
many of the features of ICP4 as an activator and repressor of transcription and also contributes to 
its regulation by ICP27 (Fig. 4).  The first 774 amino acids of ICP4 containing the N-terminal 
activation domain, the DNA-binding domain, and nuclear localization signal possess most of the 
properties associated with the full-length wild-type ICP4 (47).  This ICP4 molecule, named 
n208, retains the ability to form tripartite complexes with TBP and TFIIB on promoters 
containing ICP4 specific DNA binding sites and can repress transcription initiation from these 
promoters (80, 181).  The N-terminal region is essential for this effect.  Although this 
polypeptide can promote preinitiation complex formation on TATA boxes and activate 
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 transcription of some early and leaky-late genes in transient transfections and in vitro 
reconstituted transcription systems, in the context of lytic infection this molecule lacks the 
complete transactivation potential of wild-type ICP4 (47).  Viruses that express this 774 amino 
acid polypeptide are defective in activation of all early and leaky-late promoters impairing viral 
DNA synthesis which in turn, compromises the expression of late genes. 
 
SERINE TRACT 
 
The N-terminal activation domain of ICP4 contains a stretch of 24 residues, termed the serine-
rich region.  This peculiar stretch of serines is characteristic of all herpesvirus family ICP4 
homologs, such as HSV-2, VZV, pseudorabies virus, Marek’s disease virus, equine herpesvirus 
1, and bovine herpesvirus 1 (27, 131).  The serine-rich region of HSV-1 ICP4 contains consensus 
sites for phosphorylation by cellular protein kinase A (PKA), protein kinase C (PKC) and casein 
kinase II (208, 209).  Although phosphorylation is not essential for activator function, the serine-
rich region is a major determinant for phosphorylation of ICP4 in that this region itself or the 
phosphorylation of this region increases the phosphorylation of the rest of ICP4.   
Viral mutants in which the serine-rich region of ICP4 has been deleted exhibit reduced 
viral yields and delayed E and L gene expression in tissue culture.  Yet this serine tract can be 
deleted without detrimental consequence to lytic growth in tissue cultures.  However, deletion of 
this serine rich region results in a virus that is completely impaired for viral growth in the 
trigeminal ganglia (10).  In the trigeminal ganglia these viruses express only low levels of IE and 
E proteins and do not appear to replicate DNA.  A block for replication in the trigeminal ganglia 
of infected mice suggest that the polyserine tract of ICP4 provides an activity required for viral 
DNA synthesis and full lytic gene expression.  Thus the conservation of this serine tract among 
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 neurotropic herpesviruses may indicate that it imparts to ICP4 and its homologs an activity 
required for function in neurons, despite its dispensability in cell culture. 
 
DNA BINDING DOMAIN 
 
ICP4 is a sequence-specific DNA-binding protein.  The DNA binding domain of ICP4 is 
localized within residues 263 to 487 with a predicted helix-turn-helix motif structure common 
among many DNA-binding proteins (Fig. 4) (151, 175).  This region is highly conserved 
between ICP4 and its homolog in VZV.  The DNA-binding activity of ICP4 is essential to its 
function as a repressor and transactivator (47, 151, 175), since most mutations that disrupt DNA–
binding also abolish or reduce both transactivation and autoregulation.  The specific DNA 
binding-activity of ICP4 requires the direct binding of ICP4 in conjunction with TBP and TFIIB 
to high affinity ICP4-specific DNA binding sites located near the start site of transcription.  The 
ICP4 consensus binding site is a fairly degenerate consensus sequence composed of 
RTCGTCNNYNYSG, where R is purine, Y is pyrimidine, S is C or G, and N is any base (49, 
62).  These ICP4-specific binding sites are orientation specific and location specific in that these 
sites must be located within the vicinity of the transcription start site in the proper orientation 
(113, 165, 166).  When positioned at or near the transcription start of such promoters as the LAT, 
ORF-P and ICP4 promoters, these cis-elements allow ICP4 to function as a repressor.  This 
allows ICP4 to autoregulate its own transcription (80, 113, 136, 166).   
The DNA binding activity of ICP4 is also required for transcriptional activation.  Yet 
certain mutants unable to bind to ICP4 consensus binding sites are still competent for activation 
(96, 152, 174). Although low affinity ICP4 binding sites have been identified on some early and 
late promoters, ICP4 will still activate transcription in the absence of these sites.  In fact, ICP4 
23 
 does not require any single or collection of ICP4 specific binding sites for activation and it will 
activate promoters in vitro without a consensus binding sites (29, 54, 56, 85, 180).  This suggests 
that nonspecific DNA-binding will suffice for ICP4 activation (79, 96, 180).  
 
NUCLEAR  LOCALIZATION 
 
The nuclear localization signal of ICP4 is located between amino acids 723 and 732 (Fig. 4) (47, 
150).  The NLS of ICP4 contains similarities to the SV40 large T antigen regulatory protein and 
the polyoma virus large-T regulatory protein.  The large T antigen signal is recognized and 
bound by the importin 58/97 protein complex that targets nuclear proteins to the nuclear pore 
complex (75, 76, 95, 104).  Due to the similarities between ICP4 and the SV40 large T antigen, it 
is likely that ICP4 is transported into the nucleus in an analogous manner. 
 
C-TERMINAL DOMAIN 
 
With the exception of the DNA binding domain, the bulk of amino acid conservation between 
HSV ICP4 and other ICP4 homologs resides in the C-terminal one-third of ICP4 (Fig. 4).  The 
last 500 amino acids of the carboxy-terminal domain contain the greatest degree of amino acid 
similarity among all ICP4 homologs.  Although ICP4 mutants that lack the carboxyl terminal 
500 amino acids still function in DNA binding, repression and activation, viruses containing this 
truncation do not grow due to deficiencies in late gene expression.  C-terminal ICP4 mutants do 
however express some early genes, suggesting a role for the N-terminal transactivation region in 
early and leaky-late gene expression.  The amino acid similarity in within this C-terminal domain 
of ICP4 and ICP4 homologs must thus specify functions that are necessary for late gene 
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 expression.  The C-terminal 524 amino acids of ICP4 has been shown to interact with TAF250 of 
TFIID and this interaction correlates with its importance in the activation of late genes (25).  
 
1.6.4.3. Repression and activation   
 
ICP4 negatively regulates its own promoter, the LAT promoter and the promoter for ORF-P.  
Binding of ICP4 to its cognitive binding site in a tripartite complex with TFIIB and TBP is 
thought to block progression of the preinitiation complex assembly.  The regions responsible for 
ICP4 repressor activity reside within the first 774 amino acids (46, 47).  The ability of ICP4 to 
interact with TFIIB and TBP through its N-terminal activation domain is also detrimental to its 
function as a repressor (80).  In the context of infection, in the absence of the repressive effects 
of ICP4, IE genes are inefficiently shutoff and continued to be expressed at high levels (44, 51, 
128, 169). 
As the major transcriptional activator of early and late genes, ICP4 functions to increase 
the rate of transcription by increasing the rate of preinitation complex formation (78, 79).   The 
regions required for activator function reside within both the N- and C- terminal transactivation 
domains, however, these two regions activate transcription to different extents by different 
mechanisms (43, 45, 150, 175).  The N-terminal domain is important for activation of early and 
leaky-late genes while interactions with TFIID through the C-terminal domain of ICP4 are 
important for activation of late genes.  
ICP4 can activate transcription with a relatively simple set of RNA polymerase II general 
transcription factors in in vitro reconstituted transcription systems.  This has been shown to be 
true particularly for ICP4 activation of a representative late gene promoter, gC (79).  Most true 
late promoters are composed of a TATA box and an INR.  The presence of an INR in addition to 
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 a TATA box enhances the ability of ICP4 to activate transcription and the same nucleotide 
contacts that are important for classical INR function are also important for ICP4-mediated 
activation (79, 110).  The TAFs of the general transcription factor, TFIID play an essential role 
in ICP4-mediated activation of late genes (79).  TFIID is a multi-subunit complex that is 
composed of the TATA binding protein (TBP) and TBP-associated factors (TAFs) (reviewed in 
5).  TBP alone is unable to support ICP4-activation (79).  ICP4, like other cellular transcriptional 
activators, requires the co-activator functions of the TAFs of TFIID in addition to TBP to 
activate transcription (196).  ICP4 interacts with TAF250 of TFIID through its C-terminal 
transactivation domain (25).  TAF250, an integral component of TFIID, contributes to the 
interaction with the INR.  A complex consisting of TBP-TAF150-TAF250 is sufficient for INR 
activity (26, 195).  ICP4 increases the rate of preinitiation complex formation on late promoters 
through recruitment and stabilization of TFIID to the TATA box and INR through interactions 
with TAF250 (25, 78).  Thus, ICP4 assists TFIID to function more efficiently through the INR 
present on most late genes.   
 
 
1.7. TRANSCRIPTION INITIATION BY THE RNA POL II COMPLEX 
 
1.7.1. Promoter structure and elements 
 
The accurate initiation of transcription is a key stage in the regulation of gene expression for 
mammalian protein-coding genes.  The regions that regulate transcription can be separated into 
two categories: core promoter elements and regulatory elements.  Regulatory elements are gene-
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 specific sequences that are located both up and downstream of core promoter elements and serve 
as binding sites for enhancers and repressors of transcription.  Core promoter elements can 
consist of a TATA box, which is an A/T rich sequence located 25 to 30 bp upstream of the 
transcription start site, an initiator element (INR) that encompasses the start site, a downstream 
promoter element (DPE) localized approximately 30 base pairs downstream of the start site and a 
TFIIB response element (BRE).  For promoters that lack a TATA consensus, the INR can direct 
accurate transcription initiation by RNA polymerase II by itself or in conjunction with other 
promoter elements (55, 120, 177).   The presence of an INR in addition to a TATA box can serve 
to enhance the strength of that promoter, as is the case for most HSV late promoters (reviewed in 
199, 203). 
 
1.7.2. RNA Pol II machinery 
 
Transcription initiation is an orchestrated process that requires the concerted functions of 
multiple transcription factors (reviewed in 116, 124, 146, 160).  The general transcription 
machinery is composed of a ubiquitous group of factors that include RNA polymerase II and six 
general transcription factors (GTFs), TFIIA, -B, -D, -E, -F and –H that were originally identified 
biochemically as factors required for the accurate transcription initiation by RNA Pol II in in 
vitro reconstituted transcription systems.  With the exception of TFIIB, which is a single 
polypeptide of 35 kDa, all other GTFs as well as Pol II, are multi-subunit complexes of 2 to 14 
different proteins that exist as stable multi-protein complexes in solution.  Although RNA Pol II 
is a large multi-subunit enzyme, composed of 12 different proteins with a molecular mass of 
approximately 0.5 MDa that shares five of its subunits with the two other eukaryotic RNA 
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 polymerases (Pol I and III), Pol II alone is unable to recognize promoters and accurately initiate 
cellular transcription.  Initiation of transcription by Pol II requires the cooperative assembly of 
GTFs and Pol II into pre-initiation complexes (PIC) on core promoter elements.  This involves 
recognition of GTFs to various core promoter elements, which include the TATA box, the INR, 
TFIIB-response element (BRE) and downstream promoter elements (DPE) that are found in 
various combinations in different genes.  Association of the general transcription factors with 
these core promoter DNA elements then allows the specific recruitment of Pol II to the core 
promoter of all class II genes.   
The first step in PIC formation involves the binding of TFIID to the core promoter.  TFIID 
is a multi-subunit complex composed of the TBP and 14 distinct TBP-associated factors (TAFs) 
that are highly conserved from yeast to Drosophila to humans (5).  Binding of TFIID to the 
TATA box, via TBP, is the initial step of PIC assembly and is critical for the rate and efficiency 
of this process.  The TBP subunit of TFIID binds to the minor groove of the TATA box inducing 
a dramatical bend in promoter DNA, while the TAFs interact with additional downstream DNA 
sequences up to +35.  TFIID can also recognize TATA-less promoters to allow functional PIC 
formation.   
In purified reconstituted systems, TBP can function in the absence of TAFs to promote 
basal levels of transcription from TATA-containing core promoters.  However, TBP alone is 
insufficient to regulate transcription by upstream activators.  Effective response to transcriptional 
activators requires the presence of TAFs in TFIID and many activators have been shown to 
interact with TAFs to mediate activation.  TAFs also contribute to promoter selectivity by 
interacting with other basal transcription factors, other TAFs, and specific DNA sequences, such 
as the INR and downstream promoter element (DPE) or gene-specific core promoter elements.  
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 Human TAF150 is involved in INR recognition and a complex consisting of TBP, TAF250 and 
TAF150 is sufficient for INR activity in the presence or absence of a TATA box (24, 26, 105-
107, 120).  Drosophila TAF60 recognizes the DPE and allows for TFIID to function through this 
core promoter element in the absence of a TATA box (reviewed in 20).   
The binding of TFIID to the core promoter is stabilized by TFIIA and TFIIB.  TFIIA is a 
three-subunit complex that stabilizes TBP binding to the TATA box by contacting TBP and 
DNA upstream of the TATA box.  TFIIB also stabilizes the TBP-TATA interaction through 
contacts with both TBP and BRE DNA sequence that is 5’ to the TATA element.  TFIIB is 
responsible for properly positioning RNA Pol II on the start site and specifying the start site of 
transcription.  While TFIIB is essential for basal transcription directed by either TBP or TFIID, 
TFIIA is dispensable for TBP-directed basal transcription in purified systems in vitro.  However, 
it is essential for TFIID-directed basal and activated transcription.  In Chapters 4 and 5 we show 
that although required for ICP4-activation of early genes, TFIIA is downregulated during HSV 
infection and is dispensable for ICP4 activation of late genes.   
Assembly of a TFIID-TFIIA-TFIIB complex on DNA allows for the recruitment of TFIIF 
in association with RNA polymerase II.  TFIIF is a heterotetrameric factor consisting of RAP30 
and RAP74 subunits that prevents random initiation by RNA Pol II by inhibiting and reversing 
Pol II’s binding to non-promoter sites.  RNA Pol II is the enzyme that catalyzes DNA-dependent 
synthesis of mRNA.  The crystal structure of RNA Pol II has recently been derived (38) and 
described as a “jaw” like structure that clamps down onto DNA (206).  The largest subunit of 
RNA Pol II contains the essential carboxy-terminal domain (CTD) that is specific to only RNA 
Pol II.  During initiation, the unphosphorylated form of Pol II is recruited to the initiation 
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 complex.  The CTD plays key roles in the regulation of transcription initiation and coordination 
of co-transcriptional mRNA processing events.   
Although a complex of TFIIA, -B, -D, -F, and RNA Pol II is sufficient to initiate 
transcription from supercoiled DNA plasmids and pre-melted promoter template in vitro, the 
additional activities of TFIIE and TFIIH are required for efficient transcription initiation on 
linear DNA. TFIIE, a heterotetramer of 34 and 56 kDa subunits, joins the complex and recruits 
TFIIH and regulates TFIIH activities.  TFIIH is a large complex GTFs, consisting of 9 subunits 
with a molecular weight comparable to Pol II.  This 9-subunit complex with a ring-like 
architecture is the only GTF with enzymatic activities, including two ATP-dependent DNA 
helicases (XPB and XPD) that are involved in promoter melting at the transcription start site and 
in Pol II promoter clearance.  TFIIH also contains a kinase that phosphorylates the CTD of the 
largest subunit of Pol II, a step that is thought to also facilitate promoter clearance by disrupting 
interactions of the CTD with components of the PIC.  Phosphorylation of the CTD promotes the 
transition of RNA Pol II from a preinitiation complex to a stable elongation complex. 
This ordered PIC assembly has been challenged with the discovery that the un-
phosphorylated form of Pol II can be found in preassembled complexes in the form of a 
holoenzyme (reviewed in 9, 112).  These complexes vary in composition but generally include 
TFIIF, -E, -H, Pol II and components of the ‘Mediator’ complex that can be recruited in a single 
step to DNA bound TFIID/TBP-TFIIA-TFIIB complex.  After open complex formation and 
promoter clearance, the CTD-phosphorylated Pol II in association with TFIIF elongates, while 
TFIIA, -D, -E, and -H remain bound to the core promoter and TFIIB is released.  Second rounds 
of transcription initiation may not require de novo recruitment of TFIIA, -D, -E, or -H but may 
just need re-incorporation of TFIIB, TFIIF and a dephosphorylated form of Pol II. 
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2. RATIONALE 
 
 
HSV is known to cause immense changes in host cellular gene expression.  In an effort to 
collectively determine differences in the individual expression patterns of a large number of 
cellular genes during infection, microarray analysis was conducted using Incyte DNA gene chip 
arrays containing approximately 30,000 representative cellular genes.  Scatter plot representation 
of microarray analysis of wild-type (KOS at an MOI of 10) infected versus uninfected HEL cells 
showed that cellular gene expression was progressively dysregulated as a function of wild-type 
HSV infection (Fig. 5).  At 1 hour post infection, cellular gene expression was minimally 
affected as most genes (indicated as dots) could be plotted on a central axis of one (Fig. 5).  By 4 
hpi, changes in cellular gene expression were more pronounced as many genes were displaced 
from the central axis of 1, indicating that many of these genes were moderately up or down 
regulated at this time of infection (Fig. 5).  Genes that were upregulated could be located below 
the central axis of 1, whereas genes that were downregulated could be located above the central 
axis of 1.  By 8 hour post infection, cellular gene expression was highly dysregulated as 
evidenced by the greater distribution of cellular genes away from the central axis of 1 (Fig. 5).  
Expression of cellular genes at this time of infection appeared to fall into three main categories, 
those that were downregulated during infection, those that were unaffected and those that were 
upregulated during infection, with the largest group of genes being those that were repressed.  
This was not unexpected since many cellular genes have been shown to be downregulated during 
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 infection (88, 184, 201). Most importantly however, this microarray analysis showed that the 
expression of the small number of general transcription factor components present on these chips 
were also dysregulated during infection, suggesting that the expression of many more 
components of the general transcription machinery responsible for the transcription of all viral 
genes may also be perturbed. 
Changes in the mRNA abundances of components of the cellular transcription machinery 
may lead to variations in the overall composition of the basal transcription machinery available 
for the transcription cellular genes.  Alterations in the transcription machinery may contribute to 
the repression of cellular gene expression since the normal factors that make up the transcription 
machinery may be altered or not available for cellular activators to interact with or function 
through.  However since immediate-early and early genes also rely on cellular as well as viral 
activators that function though the cellular transcription machinery, any changes in the 
composition of this machinery would also effect viral immediate-early and early gene 
expression.  In contrast, late promoters do not contain binding sites for upstream activators but 
are maximally expressed late in infection suggesting that late gene expression may not require 
the normal set of cellular transcription factors necessary for immediate-early and early gene 
expression.  Changes in the composition of the transcription machinery may in fact promote the 
shift from early to late gene expression. 
ICP4 plays a major role in efficient expression of the early and late genes.  If at late times of 
infection the make up of the cellular transcriptional machinery is greatly perturbed, but late 
genes are still maximally expressed, it follows that ICP4 can still function with changes in the 
transcription machinery to promote high levels of late viral transcripts.  ICP4 is a large complex 
protein, with many unrecognized functions.  Interactions with the general transcriptional 
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 machinery may exist at various times of infection that allow optimal usage of the transcriptional 
machinery regardless of differences in the composition of the transcription machinery.   Based 
on this, we hypothesize that as infection proceeds the mRNA abundance of the Pol II 
transcription factors and their subunit composition change as a function, but that the major HSV 
transcription regulatory protein, ICP4 may function with these changes and has differential 
requirements of the general transcription factors based on the viral promoter context.  
Through cellular and biochemical methods, the goals of this study are to address the 
following: I) Identify changes in the expression patterns of the components that make up the 
cellular transcription machinery.  Changes in the mRNA abundances of all the components that 
comprise the basal cellular transcription machinery will be analyzed at early and late times of 
wild-type infection via microarray and northern blot analysis.  II) Determine whether there are 
differential requirements for any of the general transcription factors for ICP4-mediated activation 
of different promoters.  Utilizing chromatographically enriched forms of transcription factors, 
ICP4 will be tested for the ability to activate transcription from representative viral early and late 
promoters using an in vitro reconstituted transcription system.  III) Characterize and analyze the 
transcription factors of interest with ICP4 through protein-protein and protein-DNA interactions 
on early and late promoters.  DNase I footprinting analysis will be conducted on representative 
early and late promoters to delineate differences in requirements of the transcription factors of 
interest to stabilize protein-DNA interactions in the presence and absence of ICP4. 
Because HSV can be easily transmitted and is able to cause a variety of infections, some 
of which can cause severe and life-threatening diseases it is important to understand the 
mechanisms of pathogenesis for therapeutic approaches.  If we can establish exactly what 
contacts between viral (i.e. ICP4) and cellular proteins affect transcription we can use the 
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 information to develop therapeutics that block these interactions preventing viral gene expression 
of products that are cytotoxic to cells, essential for progeny production or both.  These studies 
can provide a better understanding of how viral genes are regulated and how viral genes are 
efficiently expressed late in infection.  Not only are these studies important for determining how 
viral genes are regulated, but they may also reveal novel functions of the cellular transcription 
machinery that would aid in understanding the mechanisms governing cellular gene expression.  
 
Figure 5. Incyte microarray analysis of changes in the expression of cellular genes as a function of wild-type 
HSV-1 infection  
Scatter plot representation of changes in the expression patters of 30,000 cellular genes during the progression of 
wild-type KOS infected versus uninfected (MOCK) HEL cells analyzed through Incyte microarray DNA chips.  
Complements of William Hobbs. 
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3. CHANGES IN THE EXPRESSION OF COMPONENTS OF THE GENERAL 
TRANSCRIPTION MACHINERY AS A FUNCTION OF HSV INFECTION 
 
 
3.1. INTRODUCTION 
 
Infection with herpes simplex type 1 virus profoundly alters cellular homeostasis through a 
myriad of viral induced modifications.  Many of these changes lead to a strong suppression of 
cellular gene expression with a concomitant increase in viral gene expression (88, 184, 201).  
Studies have shown that by 6 hours post infection, cellular gene expression is repressed to less 
than 40% compared to uninfected cell levels with a continuous decline thereafter (127, 184, 
187).  Within the first hours of HSV infection, the virion-associated protein vhs halts translation 
of cellular mRNA by disrupting preexisting polyribosomes and induces the degradation of 
preexisting and newly transcribed mRNA through an RNase-like activity (reviewed in 179).  The 
immediate-early protein ICP27, blocks cellular splicing mechanisms and induces nuclear 
retention of intron-containing cellular messages while it increases transport of viral intronless 
mRNAs out of the nucleus (reviewed in 170).  ICP0 causes dispersal of nuclear ND10 domains 
early during infection by inducing the degradation of ND10 proteins, including PML and Sp100, 
that is suggested would otherwise silence viral transcription (57, 84).  The combined action of 
these viral immediate-early gene products and virion components contribute to dramatic 
alterations of host gene transcription for the benefit of viral gene transcription.   
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 HSV-1 relies on the activities of the host cellular transcription machinery for efficient 
expression of all its genes and many viral induced cellular changes contribute to the redirection 
of the cellular transcription machinery from cellular to viral genes (164, 184).  Initiation of 
transcription by the host RNA polymerase II transcription machinery is a highly regulated 
process that requires the cooperative assembly of Pol II and six general transcription factors 
(GTFs), TFIIA, -B, -D, -E, -F and –H into pre-initiation complexes (PIC) on core promoters (86, 
124, 145).  With the exception of TFIIB, which is a single polypeptide of 35 kDa, all the other 
GTFs as well as Pol II are multi-subunit complexes of 2 to 14 different proteins that exist as 
stable multi-protein complexes in solution.  Recognition of these general transcription factors to 
core promoter DNA elements allows the specific recruitment of Pol II to the core promoter of all 
class II genes.  HSV encodes at least two viral regulatory proteins, VP16 and ICP4, that directly 
interact with the general transcription factors and moderate preinitiation complex (PIC) 
formation on viral promoters.  The virion-associated transcriptional regulatory protein, VP16, 
interacts with a number of the general transcription factors (GTFs) including TBP, TFIIB, 
TAF31 of TFIID, the gamma subunit of TFIIA, and the 62 kDa subunit of TFIIH (65).  These 
interactions strongly stimulate preinitiation complex formation on immediate-early promoters 
triggering the expression of these genes rapidly upon infection.  In addition, other cellular 
activators that also interact with the basal transcription machinery synergize with the effects of 
the powerful transactivation potential of VP16 to recruit and induce stabilized PIC formation on 
immediate-early gene promoters.  ICP4, an immediate-early gene product that is the major 
transcriptional activator of early and late genes, interacts with the general transcription 
machinery to both repress immediate-early transcription and to activate early and late genes.  For 
repression, ICP4 participates in a tripartite complex formation with TBP and TFIIB on ICP4 
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 specific binding sites of immediate-early promoters blocking recruitment of RNA Pol II (80, 
113, 165, 181).  For the activation of early and late genes, ICP4 interacts with TAF250 of the 
general transcription factor TFIID through its C-terminal transactivation domain resulting in 
recruitment and stabilization of TFIID to viral core promoters (25).  This serves to increase the 
rate of preinitiation complex formation on viral early and late promoters (78). 
Due to drastic alterations in cellular gene expression, the question remained whether 
these viral induced changes also had any effect on the expression of components of the cellular 
transcription machinery.  It seemed feasible that such drastic changes in cellular gene expression 
also resulted in changes in the expression levels of some of the general transcription factors that 
are required for viral as well as cellular mRNA synthesis.  Changes in the expression of the basal 
transcription machinery components may contribute to suppression of host gene expression since 
the normal composition of these factors responsible may not be available for cellular 
transcription.  However, repression of cellular gene expression occurs fairly early on during 
infection, thus it is likely that other factors such as vhs, ICP27, and ICP0 play greater roles in the 
suppression of cellular gene expression.  Because the cellular transcription machinery also 
transcribes all three classes of HSV genes, changes in the transcription machinery would most 
likely have a great impact on viral gene expression.  Late in infection, early gene expression is 
attenuated suggesting that changes in the transcription machinery may contribute to the shutoff 
of early gene expression.  Yet late in infection, late gene expression appears to proceed at high 
levels suggesting that if there are any changes in the transcription machinery viral transcriptional 
regulatory mechanism, namely ICP4, can operate with these changes to transcribe viral genes.  
Perhaps changes in the transcription machinery during infection may be yet another mechanism 
for augmenting the progression from one viral kinetic class of genes to the next. 
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 Microarray analysis was used to examine changes in the mRNA abundances of all the 
components that make up the general transcription machinery during HSV infection.  Because 
the complete transcriptional machinery is a large complex composed of 43 distinct proteins with 
a total mass of over 2.2-MDa, microarray was the choice method of analysis.  Microarray cDNA 
chips containing all the components of the general transcription factors were constructed in-
house and changes in the mRNA abundances of these factors were examined at early (4 hpi) and 
late (8 hpi) times post wild-type infection.  Microarray analysis indicated that components of the 
general transcription factors were changed as a function of infection and some of these changes 
were confirmed through Northern blot analysis.  Together this provides evidence that expression 
of components of the general transcription machinery are altered during infection, suggesting 
that late in infection the composition of the transcription machinery may be distinct. 
 
 
3.2. MATERIALS AND METHODS 
 
3.2.1. Microarray analysis 
 
Either 2 µg of total RNA or 3 µg of poly (A)+ RNA harvested from uninfected and KOS 
(multiplicity of infection of 10) infected HEL cells at 4 and 8 hpi were used for hybridization to 
chips arrays made in-house containing PCR amplified cDNA fragments representing the mRNAs 
encoding components of the general transcription machinery.  Microarray chip construction, 
hybridization and data analysis was conducted as previously described (53).  
 
38 
 3.2.2. Northern blot analysis 
 
Poly A+ RNA (2 µg) harvested from uninfected and KOS (MOI of 10) infected HEL cells at 4 
and 8 hpi was resolved by denaturing formaldehyde-agarose gel electrophoresis, transferred to 
nitrocellulose membranes and probed, washed and exposed as previously described.  32P-labeled 
probes for Northern analysis, labeled by nick translation using [α-32P]dCTP and [α-32P]dGTP, 
were generated from PCR amplified products from plasmids that were used for microarray chip 
construction.   TFIIA probes were generated from pQE-TFIIAαβ and pQE-TFIIAγ by nick 
translation using [α-32P]dCTP and [α-32P]dGTP. 
 
 
3.3. RESULTS 
 
Changes in the mRNA abundances of components of the general transcription machinery 
observed from at least three independent microarray hybridization experiments were averaged 
and graphed as fold change in log ratio.  The ratios are a comparison of uninfected (MOCK) 
versus wild-type KOS (MOI of 10) infected HEL cells harvested at 4 and 8 hours post infection.  
Genes that were not affected during infection at the indicated time point, remain at a ratio of one.  
Genes that were downregulated fall below the ratio of one and those that were upregulated rise 
above the ratio of one. 
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 3.3.1. Changes in the expression of components of the RNA Pol II enzyme and the 
general transcription factors. 
 
RNA polymerase II is a large multi-subunit enzyme, composed of 12 different proteins.  
Microarray analysis of all the subunits of RNA polymerase II showed that while the largest 
subunit of RNA Pol II (220 kDa) was upregulated during infection, most of the smaller subunits 
of Pol II were downregulated during wild-type infection (Fig. 6A).  Northern blot analysis 
confirmed an approximate 2-fold increase in expression of the largest subunit of RNA Pol II by 4 
hpi and validated the decreased expression of two of the smallest subunits of polymerase II, 7.6 
kDa and the 7.0 kDa, by 8 hpi (Fig. 6B). 
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Figure 6.  Microarray and northern blot analysis of changes in the expression of subunits of the RNA 
polymerase II enzyme during wild-type HSV infection. 
A.  Bar graph representation of the mRNA abundances of all twelve subunits of RNA Pol II at early (4 hpi) and late 
(8 hpi) times post wild-type (KOS at MOI = 10) infection of HEL cells.  An average of at least three microarray 
experiments were calculated and graphed as log ratio changes in wild-type versus uninfected HEL cells.  B.  
Northern blot analysis of poly A+ mRNA harvested at 1, 4, and 8 hour post wild-type infected (I) and uninfected (U) 
HEL cells probed for the indicated subunits of RNA Pol II. 
 
Microarray analysis of components of the general transcription factors showed that the 
expression of the smallest subunit of TFIIA (12 kDa subunit) was sharply downregulated during 
infection (Fig. 7A).  There was also a decrease in the expression of the RAP74 subunit of TFIIF 
and a slight decrease in the 44 kDa subunit of TFIIH by 8 hpi (Fig. 7A).  In contrast the 56 kDa 
subunit of TFIIE, and to a much lesser extent the RAP30 subunit of TFIIF, were upregulated by 
8 hpi (Fig. 7A).  Northern blot analysis confirmed the downregulation of the smallest subunit of 
TFIIA, the γ−subunit, as well as of the other two subunits of TFIIA, α and β, such that by 8 hpi, 
the mRNA abundance was undetectable by northern blot analysis (Fig. 7B).  Northern analysis 
also confirmed the decreased expression of the 44 kDa subunit of TFIIH (Fig. 7B).  
 
41 
  
42 
  
 
Figure 7.  Microarry and northern blot analysis of changes in the expression of components of the general 
transcription factors during HSV infection. 
A.  Microarray changes in the mRNA abundances of subunits of the general transcription factor during wild-type 
infection.  B.  Northern blot analysis of poly A+ mRNA harvested at various times post wild-type infected (I) and 
uninfected (U) HEL cells that were probed for the indicated general transcription factor subunits. 
 
When examining the TBP-associated factors of the general transcription factor TFIID 
through microarray, many factors appeared to be diffferentially expressed as a function of 
infection (Fig. 8A).  The expression of TAF55 suggested to sharply decrease as a function of 
infection, was also shown to be dramatically downregulated during infection through northern 
analysis (Fig. 8B).   
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Figure 8.  Microarry and northern blot analysis of changes in the mRNA abundances of the TBP-associated 
factors of the general transcription factor TFIID during HSV infection. 
A.  Changes in the mRNA abundances of subunits of the TBP-associated factors of TFIID.  B.  Northern blot 
analysis of poly A+ mRNA harvested at various times post wild-type infected (I) and uninfected (U) HEL cells 
probed for TAF55. 
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 3.4. DISCUSSION 
 
Using microarray and northern blot analysis, changes in the expression of components of the 
general transcription machinery were analyzed at early (4 hpi) and late (8 hpi) times post wild-
type infection.  Many changes in the mRNA abundances of these components were observed 
through microarray analysis with some being confirmed through northern blot analysis.  Only a 
small number of these components were observed to be upregulated during infection while a 
larger number were observed to be downregulated during infection and these changes were 
particularly evident at later times of infection.  These results suggest that changes in the 
expression of these components may result in alterations in the composition of the general 
transcription machinery available for transcription particularly at late times of infection.    
 
3.4.1. Impact on cellular and viral gene expression 
 
The general transcription machinery is essential to the expression of both cellular and viral 
genes.  Alterations in the composition of the cellular transcription machinery may contribute to 
the global decline of host genome transcription (99).  However, shutdown of host transcription is 
likely due to many viral induced mechanisms that exist earlier on during infection.  Yet it is 
likely that alterations in the cellular transcription machinery can also help keep host genome 
transcription down.  Because alterations in the composition of the cellular transcription factors 
occur later on in infection, these changes may have a greater impact on viral gene expression 
than cellular gene expression.  At 4 hours post infection during the peak expression of viral early 
genes, the observed changes in the abundance of the general transcription machinery are only 
commencing suggesting that the early gene expression is most likely not affected prior to this 
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 time.  Since early promoters have cis-acting sequences that are common to cellular promoters, 
such as Sp1 and CCAAT box sites, viral early gene expression and cellular gene expression 
share similar requirements of the cellular transcription machinery.  Alteration in the transcription 
machinery at this early time of infection would not be highly beneficial for early gene 
expression.  ICP4 is also required for efficient early gene expression, yet the exact cellular 
requirements of ICP4-mediated activation of early genes are not well understood.  For early gene 
activation, ICP4 synergizes with the activities of cellular activators, such as Sp1 to activate early 
genes.  ICP4 and cellular activators most likely require the normal composition of the cellular 
transcription machinery for efficient early gene expression.  The disruption or alteration of the 
normal composition would have severe consequences on early gene expression.  The inability of 
cellular activators to function with altered transcription factors may in turn compromise ICP4’s 
ability to activate transcription of early genes.  With cellular activators unable to co-opt altered 
general transcription factors or operate in the absence of these transcription factors, these 
activators lose the ability to transactivate viral early genes and ICP4, although highly abundant at 
the time, is unable to activate transcription of early genes without the activities of these 
activators. Thus changes in the expression of the transcription machinery beyond 4 hpi, 
coincident with the time early genes are turned off may contribute to shutdown of viral early 
gene expression. 
Late in infection (8 hpi), the abundance of the general transcription factors is grossly changed 
in comparison to earlier times of infection (4 hpi), suggesting that if viral gene expression would 
be affected, late gene expression would be impacted the most.  However viral late gene 
expression proceeds efficiently and at high levels suggesting that if the normal composition of 
the cellular transcription machinery is altered, viral mechanisms exist to circumvent the normal 
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 requirements.  Late promoters are quite simplistic lacking many of the characteristics of viral 
early and cellular promoters.  Late promoters, unlike any cellular promoters, are devoid of any 
influential upstream cis-activating sequences.  Although these promoters still contain a TATA 
box, the only other element in addition to the TATA box that has been shown to be required for 
late gene expression is an INR (79, 110).  In in vitro reconstituted transcription systems, ICP4 
alone will activate late gene transcription to high levels with a simple set of general transcription 
factors in the presence of TFIID on late promoters that contain an INR element (79).  Due to this 
and the fact that late promoters do not require cellular transactivators other than ICP4 for 
expression, late gene transcription may have differential requirements for the basal transcription 
machinery for expression.  Since ICP4 alone is sufficient to activate late genes at high levels, 
ICP4 may cooperate in an optimal manner with a different set of factors late in infection to 
efficiently activate transcription of late genes by replacing or substituting for functions inherent 
to these factors.   
 
3.4.2. Changes in the cellular transcription machinery 
 
Infection with HSV caused the decreased expression of many components of the general 
transcription machinery more than it increased.  A peculiar observation was the increased 
expression of the largest subunit of the RNA polymerase II enzyme.  In contrast, the smaller 
subunits of pol II were observed to decrease during infection.  The largest subunit is unique in 
that it contains a carboxyl-terminal domain that is absent from RNA pol I and III and plays an 
essential role in RNA pol II activity  (reviewed 39, 144).  Deletion of the CTD is lethal in mouse, 
Drosophila, and yeast.  Phosphorylation of the CTD is important in the initiation and elongation 
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 of transcription.  Alternative states of phosphorylation are associated with different steps in the 
transcription cycle.  The unphosphorylated CTD (IIa) is the form that is recruited to and 
assembled into the preinitiation complex.  Extensive phosphorylation of the CTD (IIo) 
corresponds with the transition of RNA pol II from transcription initiation to elongation and is 
necessary for the progression of RNA synthesis.  Many important transcription accessory factors 
are associated with the both forms of the CTD.  During transcription initiation, the Mediator 
complex is associated with the CTD while splicing factors are associated during elongation.  
Interestingly during HSV infection, a form that deviates from the hypo- or hyper- phosphorylated 
form can be detected, termed the intermediate form (IIi) (164).  This form runs intermediate to 
the unphosphorylated and the hyperphosphoylated forms of the CTD on SDS-polyacrylamide 
gels and is the predominant form late in infection.  Two viral proteins, ICP22 and UL13 are 
responsible for this aberrantly phosphorylated form of the CTD (121).  While the significance of 
this modification is not well understood it has been suggested that these changes may be 
responsible for the redirection of the transcription machinery from cellular to viral gene.  In 
addition to redirecting the transcription machinery to viral genes, the aberrant phosphorylation of 
the CTD, the increased expression of this subunit, and the decreased expression of the smaller 
subunits of Pol II during infection may have a greater impact on viral gene expression.  
Transcription with the RNA pol II enzyme harvested from infected cells has not been assessed 
on viral early and late genes.  It would be worthwhile to examine the properties of infected RNA 
Pol II in the presence of the other GTFs on the transcription of early and late genes and its ability 
to support ICP4-mediated activation.  It is possible that late in infection cellular activators are not 
able to function with this altered RNA Pol II enzyme resulting in the shutdown of not only 
cellular gene expression but also viral early gene expression that require the actions of these 
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 cellular activators.  Late genes have no such requirements for cellular activators and it is possible 
that ICP4 can function with the infected form of RNA Pol II to efficiently activate late genes.  
This may be one mechanism that promotes the shutoff of early genes while allowing late gene 
expression to proceed.   
 The TBP-associated factor 55 (TAF55) of the general transcription factor TFIID was also 
suggested to be downregulated during infection though both microarry and northern blot 
analysis. TAF55 has recently been described to interact with TAF250 of TFIID and to inhibit its 
acetyltransferase (AT) activity (70).   Reconstituted transcription showed that addition of 
exogenous TAF55 decreased TAF250-dependent transcription while having no effect on 
TAF250-independent transcription. TAF250-dependent transcription was decreased due to 
TAF55’s ability to inhibit TAF250’s AT activity.  Given that late gene expression relies on 
TAF250 for INR function (48), late promoters could be considered TAF250-dependent.  Future 
studies should be aimed at determining if the decreased expression of TAF55 during infection 
affects TAF250-dependent viral promoter activity.  The presence of TAF55 could be 
hypothesized to block TAF250-promoter dependent late gene expression at early times of 
infection by blocking TAF250 AT activity.  Late in infection the decreased abundance of TAF55 
may lift the block in TAF250 activity resulting in an increase in the expression TAF250-
dependent late promoters.  This may be one of the mechanisms to prevent expression of late 
genes at early times of infection.   
 All three subunits of the general transcription factor TFIIA were suggested to be 
downregulated during wild-type infection through microarray and northern blot analysis.  In the 
subsequent chapters we correlate the decreased expression of TFIIA with the attenuation of early 
gene expression.  We show that TFIIA is required for efficient ICP4-activation of a viral early 
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 promoter but that late in infection, TFIIA is downregulated and is not required for efficient ICP4-
activation of an INR containing late promoter.  We also show that TFIIA is not required for 
ICP4-activation of an INR-containing late promoter because ICP4 can substitute for TFIIA in 
stabilizing the binding of TFIID to the TATA box in the presence of a functional INR.  Because 
TFIIA is required for ICP4-mediated activation of early genes, but is not required for ICP4-
mediated activation of INR-containing late genes, the decreased expression of TFIIA may serve 
as yet another mechanism to shutoff early gene expression, while having no effect on late gene 
expression. 
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4. DIFFERENTIAL CELLULAR REQUIREMENTS FOR THE ACTIVATION OF 
HSV-1 EARLY (TK) AND LATE (GC) PROMOTERS BY ICP4 
 
 
4.1. ABSTRACT 
 
The herpes simplex virus, type 1 immediate early protein, ICP4, activates the transcription of 
viral early and late genes and is essential for viral growth.  It has been shown to bind DNA and 
interact with components of the general transcription machinery to activate or repress viral 
transcription, depending upon promoter context.  Since early and late gene promoters have 
different architectures, and cellular metabolism may be very different at early and late times after 
infection, the cellular requirements for ICP4-mediated activation of early and late genes may 
differ.  This hypothesis was tested using tk and gC as representative early and late promoters, 
respectively.  Nuclear extracts and phosphocellulose column fractions derived from nuclear 
extracts were able to reconstitute basal and ICP4-activated transcription of both promoters in 
vitro.  When examining the contribution of the general transcription factors on the ability of 
ICP4 to activate transcription, the fraction containing the general transcription factor TFIIA was 
not essential for ICP4 activation of the gC promoter, but was required for efficient activation of 
the tk promoter.  The addition of recombinant TFIIA restored the ability of ICP4 to efficiently 
activate the tk promoter, but had no net effect on activation of the gC promoter.  The 
dispensability of TFIIA for ICP4 activation of the gC promoter required an intact INR element.  
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 In addition, microarray and northern blot analysis indicated that TFIIA abundance may be 
reduced at late times of infection.  This decrease in TFIIA expression during infection and its 
dispensability for activation of late but not early genes suggests one of the many possible 
mechanisms for the transition from viral early to late gene expression. 
 
 
4.2. INTRODUCTION 
 
During the lytic cycle of herpes simplex type 1 (HSV-1) infection, synthesis of viral gene 
products occurs in three temporally regulated phases, immediate-early (IE or α), early (E or β) 
and late (L or γ) (92).  Each gene contains its own promoter regulatory region and is transcribed 
by the cellular RNA polymerase II (Pol II) transcriptional machinery (6, 36).  Each class of 
genes, however, differs with respect to its promoter structure, which decreases in complexity 
from IE to E to L genes (199, 203).  These class specific differences in promoter structure may 
be important in determining the ability to nucleate the assembly of stable preinitiation complexes 
at various phases of infection, in part mediating kinetic class-specific transcription (200, 216). 
Five immediate early genes constitute the first set of genes to be transcribed upon HSV-1 
infection. They are maximally expressed approximately 2 to 4 hours post infection (hpi) (92).  
These genes are expressed without prior viral protein synthesis due to the viral transactivator, 
VP16 (11, 23).  VP16, a viral tegument protein, is released into the cell upon infection, 
associates with cellular proteins Oct1 and HCF to bind the virus specific TAATGARAT 
elements found exclusively on immediate-early gene promoters to activate transcription from 
these promoters (69, 142, 143).  In addition to a TATA box and TAATGARAT elements, sites 
52 
 exist for cellular cis-acting factors such as Sp1 and others that contribute to enhanced 
transcription (72).  
Of the immediate early proteins, ICP4 is absolutely required for progression beyond the 
immediate early phase of gene expression due to its role a transcriptional activator of early and 
late genes (31, 43, 44, 51, 58, 74, 140, 141).  As a transactivator, ICP4 functions to increase the 
rates of transcription by increasing the rate of transcription complex assembly on promoters (78).  
ICP4 interacts with components of the basal transcription apparatus to either activate or repress 
transcription (25, 79-81, 113, 181).  Although ICP4 contains a DNA binding region that is 
essential to activation (47, 63, 137, 151, 175), no specific ICP4 binding sites have been identified 
on early and late promoters that are responsible for activation (56, 95, 180).  Deletion of ICP4 
severely impairs expression of early and late genes (44).  However, certain mutations in ICP4 
that have no effect on early gene transcription do not allow late gene expression, suggesting that 
ICP4 may act differently on early and late promoters (43, 47). 
Efficient transcription of the β or early genes is strictly dependent on the presence of 
functional α proteins, particularly ICP4 (44, 51, 93, 102, 156, 157).  Early promoters differ from 
IE promoters in that they lack the viral specific TAATGARAT sequences present in IE 
promoters.  However they are similar to IE promoters in that they contain a TATA box and retain 
upstream cellular activating sequences such as Sp1 and CCAAT boxes, that contribute to 
activation of these genes (56, 72, 188).  Their expression peaks 4 to 6 hpi and is subsequently 
shut off.   
The γ or late genes are the last set of genes that are expressed.  They are categorized as 
either leaky-late (γ1) or strict-late (γ2), depending on their requirement for DNA synthesis for 
expression (reviewed in 199).  The γ1 genes can be suboptimally expressed in the absence of 
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 viral DNA synthesis, whereas the γ2, or true late genes, have a strict requirement for viral DNA 
synthesis (32, 90-92, 102).  True late promoters are clearly distinct from immediate-early and 
early promoters.  These promoters are relatively simple in structure, because while they contain a 
TATA box, they are devoid of any essential upstream activating sequences (64, 83, 91, 94, 100).  
Only two known elements downstream from the TATA box are important for late gene 
expression, the initiator element (INR), which overlaps the transcriptional start site, and the 
downstream activating sequence (79, 82, 83, 94, 185).  ICP4 has been shown to activate 
transcription from the true late gC promoter maximally when both TATA box and INR are 
present (79).  Mutations in the INR element of this promoter significantly reduce ICP4 activated 
transcription both in vitro and in vivo indicating the importance of this element for late gene 
expression (110).   
The basal RNA Pol II transcription machinery is composed of at least seven general 
transcription factors (GTFs), including TFIIA, -B, -D, -E, -F and -H, and Pol II, which assemble 
on core promoters in a coordinated manner or, as more recently proposed, as a preassembled 
holoenzyme complex (213).  TFIID is a multiprotein complex containing a TATA binding 
protein (TBP) and 10 to 14 tightly associated subunits known as TAFs or TBP-associated factors 
(52, 218).  Binding of TFIID to the TATA box, via TBP, is critical for the rate and efficiency of 
preinitiation complex assembly (18, 94, 214).  In reconstituted transcription systems, TBP can 
function in the absence of TAFs to promote basal levels of transcription from TATA-containing 
core promoters (19).  However, TBP alone is insufficient to support activated transcription by 
both viral and cellular activators, such as Sp1, VP16, and ICP4.  Effective response to these 
activators requires TAFs in TFIID and many activators have been shown to interact with TFIID 
through TAFs (21, 73, 77).  TAFs also contribute to promoter selectivity by interacting with 
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 other basal transcription factors, other TAFs, and specific DNA sequences, such as the INR 
element (105, 106).  TAF250 is an integral component of the TFIID complex that along with 
TAF150 and TBP has been shown to interact with the eukaryotic INR element (26, 107, 195).  
Interestingly, ICP4 was found to interact with TAF250 of TFIID through its C-terminal domain 
(25). 
The GTF, TFIIA, binds TBP and stabilizes TBP binding to the TATA box (18, 35, 97, 
115, 123).  It is not required for basal transcription when reconstituted with TBP and the 
remaining GTFs.  However, it has been shown that activator-enhanced transcription is not only 
mediated through the TAFs in TFIID, but is also dependent on TFIIA (40, 111, 122, 147, 189, 
211).  TFIIA is composed of three subunits (α, β, and γ).  The smallest subunit (γ) is required for 
the ability of TFIIA to stabilize TBP binding to the TATA box and is essential for activated 
transcription by upstream activators such as Sp1, VP16, NTF-1, and the Epstein-Barr virus 
activator Zta (40, 118, 148, 211).  Mutations in the γ-subunit have been shown to disrupt 
transcriptional activation by VP16, GAL4-CTF, AP-1 (147).  However, in vitro transcription 
studies have shown that TFIIA is dispensable for activation of the HSV gC promoter by ICP4 
(79). 
The cellular requirements for activation of early promoters by ICP4 have not been 
studied.  Given that HSV infection has a profound effect on cellular gene expression and 
metabolism, it is possible that the cellular transcription machinery is different at times when 
early and late genes are transcribed.  To this end, we examined features of the general 
transcription machinery that contribute to ICP4 activation of two structurally distinct promoters, 
the early (tk) and the true late (gC) promoters, using a reconstituted in vitro transcription system.  
We showed that the general transcription factor TFIIA was required for efficient ICP4-activation 
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 of the early tk promoter, but was not essential for efficient ICP4-activation of the late gC 
promoter.  The dispensability of TFIIA for activation of the gC promoter required a functional 
INR element.  Addition of TFIIA greatly stimulated ICP4’s ability to activate transcription of a 
mutated INR, suggesting that in the absence of an initiator element, activation by ICP4 requires 
the additional activities of TFIIA to stabilize TFIID binding to the promoter.  In addition, we 
found that TFIIA subunits mRNA abundance was greatly reduced in cells late in infection.  
These data altogether suggest that at late times of infection the abundance of TFIIA may decline, 
potentially downregulating ICP4 activation from early promoters.  Changes in the abundance of 
TFIIA would have little effect on the activation of true late promoters by ICP4, since they 
possess INR elements.  This would allow for efficient expression of late genes while turning 
down expression of early genes. 
 
 
4.3. MATERIALS AND METHODS 
 
4.3.1. Cells and Viruses 
 
The KOS strain of HSV-1 was used to infect HEL cells for northern blot analysis and Vero cells 
for ICP4 purification.  HeLa cells were used to prepare nuclear extracts and phosphocellulose 
column fractions. 
 
4.3.2. Preparation of phosphocellulose fractions, human and recombinant TFIIA and 
ICP4 
56 
 Phosphocellulose fractions were prepared from 10 L of HeLa nuclear extracts as previously 
described (25, 50).  Approximately 15 ml of nuclear extract at 9.2 mg/ml was loaded over a 15 
ml packed column volume of phosphocellulose (P11) resin and eluted as previously described 
(50).  Approximately 96 mgs of total protein eluted, 44% in the A fraction (42 mg in a 20 ml 
pool), 29% in the B fraction (28 mg in an 8 ml pool), 16% in the C fraction (16 mg in a 6 ml 
pool), and 11% in the D fraction (10 mg in a 6 ml pool). All fractions were dialyzed against 
D100 buffer (20 mM HEPES [pH 7.9], 10% glycerol, 100 mM KCl, 2 mM EDTA, 1 mM 
ditiothreitol, 2 mM phenylmethylsulfonyl fluoride) for use in transcription reactions.  Human 
TFIIA was purified from the first phosphocellulose fraction (the A fraction) by further 
fractionation on DEAE-Sephacel (25, 160).  The 0.5 M KCl eluate (AB fraction) from this 
column, containing TFIIA, was ammonium sulfate precipitated (0.42 mg/ml), resuspended in 
buffer D100 and loaded over a Superose 12 gel filtration column equilibrated with D100, as 
described by Reinberg et al. to purify human TFIIA (160).  Recombinant human TFIIA was 
produced from uncleaved α/β and γ subunits carrying histidine tags from over expressing M15 
bacteria harboring pQE-TFIIAαβ and pQE-TFIIAγ (148).  The two polypeptides were 
independently purified on Ni-NTA agarose columns under denaturing conditions and were 
renatured separately or in equimolar amounts to produce recombinant TFIIA (rTFIIA) as 
described elsewhere (111).  ICP4 was purified from wild-type (KOS) infected Vero nuclei as 
previously described (110).  Purified rTFIIB used in transcription reactions and purified rTBP 
used in gel shift analysis were previously described (25). 
 
4.3.3. In vitro transcription and primer extension 
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 The plasmids pLSWT (95), pgCLS1 (79) and pgCLS8  (110) were used as templates for in vitro 
transcription reactions. Reconstituted transcription and primer extension analysis reactions were 
carried out as previously described (110).  Supercoiled DNA templates (100 ng) were incubated 
with nuclear extract or mixtures of phosphocellulose fractions in the presence or absence of 
approximately 250 ng ICP4.  Phosphocellulose fractions were added back based on their percent 
contribution to the total protein recovered from the phosphocellulose column to 55 µg per 
reaction.  For each reaction mixture, 11.5 µl of the A fraction, 4.6 µl of the B fraction, 3.4 µl of 
the C fraction, 3.2 µl of the D fraction and 1 µl of 0.31 mg/ml rTFIIB was used.  Where the A 
fraction was substituted, 3 µl of the AB fraction, 3 µl of Superose 12 purified TFIIA, or the 
indicated amount of rTFIIA was used. 
 
4.3.4. Electrophoretic mobility shift assay 
 
The EcoRI-BamHI fragment of the plasmid p4 (113) containing a TATA box and an ICP4 
binding site was end labeled with 32P using polynucleotide kinase, purified and quantified. DNA 
binding reaction mixtures (30 µl) contained 12.5 mM HEPES (pH 7.8), 60 mM KCl, 12.5% 
glycerol, 5 mM MgCl2, 0.5 mg/ml BSA, 20 mM β-mercaptoethanol, 25 µg poly(dG)-
poly(dC)/ml and the DNA probe (104  cpm) and were incubated with protein samples at 30oC for 
30 minutes.  The amounts of protein used in the binding reactions were 15 ng TBP, 60 ng of 
rTFIIAαβ or 15 ng of rTFIIAαβγ.  After 30 minutes, 1 µl of anti-TFIIAγ was added where 
indicated and incubated for an additional 15 min at 30oC.  Reactions were resolved on 
nondenaturing 4% 0.5X Tris-borate-EDTA acrylamide gels and exposed to film. 
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 4.3.5. Northern blot analysis 
 
Poly A+ RNA (2 µg) harvested from uninfected and KOS infected (multiplicity of infection of 
10) HEL cells at 4 and 8 hpi was resolved by denaturing formaldehyde-agarose gel 
electrophoresis, transferred to nitrocellulose membranes, and probed, washed and exposed to 
film as previously described (53).  32P-labeled probes were generated from pQE-TFIIAαβ and 
pQE-TFIIAγ (147) by nick translation using [α-32P]dCTP and [α-32P]dGTP. 
 
 
4.4. RESULTS 
 
4.4.1. Reconstitution of basal and ICP4 activated transcription on early (tk) and late 
(gC) promoters in vitro 
 
It has previously been shown that nuclear extracts prepared from uninfected HeLa cells support 
basal and ICP4-activated transcription from both an early (tk) and a late (gC) promoter (79).  
When more purified GTF systems are used instead of nuclear extracts, ICP4 efficiently activates 
the gC promoter (25, 79).  However, ICP4-activated transcription of the tk promoter has not been 
tested in different GTF systems.  To delineate any differences in requirements for cellular 
transcription factors for the activation of early and late promoters, we first set out to examine the 
contribution of these factors in a crudely fractionated transcription system.  The first step in a 
commonly utilized strategy for the purification of the GTFs from nuclear extract involves 
fractionation on phosphocellulose columns (Fig. 9A).  Four fractions are generated, A, B, C, and 
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 D, depending on the salt concentration used for elution (0.1, 0.3 M, 0.5 M and 1 M KCl, 
respectively).   One or more of the GTFs can be found in each fraction (TFIIA is found in the A 
fraction, and TFIID is found in the D fraction).  To reconstitute transcription, each fraction was 
added back as a percentage of the total protein amount recovered (see Materials and Methods).  
Equivalent amounts of protein were used in reconstitution experiments with both the tk and gC 
promoters, in the presence and absence of purified ICP4.  As observed in Fig. 9B, both basal and 
ICP4-activated transcription of the tk and gC promoters were efficiently reconstituted using 
fractions A through D, with the addition of rTFIIB.  Apparently, insufficient quantities of TFIIB 
were recovered in the C fraction to reconstitute transcription. 
 
 
Figure 9.  Phosphocellulose column fractions reconstitute basal and ICP4 activated transcription from early 
(tk) and late (gC) promoters.   
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 A.  Scheme for transcription factor fractionation of nuclear extract on phosphocellulose resin column generating 
four distinct fractions (A, B, C, and D) that contains one or more of the basal transcription factors.  The further 
fractionation of hTFIIA on DEAE and superose 12 columns is also diagrammed.  B.  The ability of 
phosphocellulose column fractions to reconstitute transcription on representative early and late promoters was 
assayed for in the presence and absence of purified ICP4.  Each fraction was added back based on the present 
contribution to the total amount of protein recovered from the column to equal 55 ug of protein per each reaction 
and compared to 60 ug of nuclear extract.  Phosphocellulose fractions A through D in the presence of added 
recombinant TFIIB were able to support basal and ICP4 activated transcription on both tk and gC promoters. 
 
Since each phosphocellulose fraction was enriched for one or more of the basal 
transcription factors in addition to other factors that play a role in transcription, the contribution 
of each phosphocellulose fraction to basal and ICP4-activated transcription of both the tk and 
was promoters was assessed (Fig. 10).   Each fraction was individually omitted from the 
reactions with the tk and gC promoters, and transcription was assessed in the presence and 
absence of ICP4.  The most striking result of this analysis was the differential requirement of the 
A fraction for ICP4 activation of the tk and gC promoters (Fig. 10).  The A fraction was not 
required for efficient activation of the gC promoter by ICP4.  In contrast, activation of the tk 
promoter by ICP4 in the absence of the A fraction was very inefficient.  This suggests that some 
factor or factors present in the A fraction are crucial for ICP4 activation of the tk promoter, but 
not for activation of the gC promoter. 
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Figure 10.  The A fraction is required for efficient ICP4 activation of the tk promoter but is not essential for 
activation of the gC promoter.   
The contribution of each phosphocellulose fraction to basal and ICP4 activated transcription was assayed on both 
early and late promoters by omitting each fraction from the reaction in the presence and absence of ICP4.  Most 
notable was the differential requirement for the A fraction for ICP4 activation of the early (tk) vs. late (gC) 
promoter. 
 
4.4.2. Differential requirements for TFIIA in activation of the gC and tk promoters by 
ICP4 
 
Because the GTF TFIIA is a component of the A fraction, we sought to further fractionate this 
factor to determine its relevance in the activation of the tk promoter by ICP4.  Human TFIIA was 
further fractionated by chromatography on a DEAE-Sephacel column.  The bulk of TFIIA 
activity eluted in the 0.5 M KCl wash, also known as the AB fraction (Fig 9A).  To assess its 
contribution to ICP4 activation, the AB fraction was substituted for the A fraction in reactions 
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 with both tk and gC promoters (Fig. 11).  In the absence of the A fraction, ICP4 efficiently 
activated the gC promoter, and the addition of AB had little effect on ICP4 activation.  In 
contrast, omission of the A fraction highly diminished the ability of ICP4 to transactivate the tk 
promoter.  Addition of the AB fraction, however, restored the ability of ICP4 to efficiently 
activate the tk promoter.  These data suggests that this fraction, which is known to contain 
TFIIA, is important for activation of the tk promoter by ICP4 but is dispensable for activation of 
the gC promoter. 
 
 
Figure 11.  The AB fraction restores ICP4’s ability to efficiently activate the early (tk) promoter but has no 
net effect on activation of the late (gC) promoter.   
The phosphocellulose A fraction was further fractionated on DEAE-sepharose (Fig 3A) and the 0.5 M KCl wash 
(AB fraction) containing the general transcription factor TFIIA, was tested for its ability to substitute for the A 
fraction in ICP4 activation.  The AB fraction was able to efficiently restore ICP4 activation of the tk promoter but 
had no effect on activation of the gC promoter. 
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 TFIIA was further purified from the AB fraction by gel filtration on Superose 12.  Fractions 
from the Superose 12 column were tested for the ability to compliment ICP4 activation of the 
early tk promoter (Fig. 12A).  Complementing activity was most abundant in fractions 6 and 7, 
which also corresponded a molecular weight of 82 kDa, in accordance with the previously 
published molecular mass of the TFIIA complex and its elution profile on Superose 6 (160).  The 
ability of this form of TFIIA to support activation of the tk promoter was compared to that of the 
AB fraction and found to substitute as well as, or better than the AB fraction in restoring the 
ability of ICP4 to activate the tk promoter (Fig. 12B).  This indicated that TFIIA found in the A 
fraction was factor responsible for efficient activation of the tk promoter by ICP4. 
 
Figure 12.  Complementation of ICP4 activation of the tk promoter by superose 12 fractions.   
A.  Complementing activity was further purified from the AB fraction of DEAE-sepharose by superose 12 gel 
filtration.  Each fraction was assayed for its ability to support ICP4 activation from the tk promoter.  The most 
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 abundant complementing activity was found in fractions 6 and 7.  This eluted at the size of TFIIA previously 
reported.  B.  Superose 12 purified TFIIA was substituted for the A or AB fraction and found to efficiently support 
ICP4 activation of the tk promoter. 
 
To strengthen the interpretation that TFIIA was critical for the activation of tk and to rule 
out the possibility that some factor co-purifying with TFIIA was contributing to the stimulatory 
effect on the tk promoter, recombinant TFIIA was produced and used as an alternate source.  
Human TFIIA is comprised of three subunits, α, β and γ, which have sizes of 35-, 19- and 13-
kDa, respectively.  The α- and β- subunits of the human form are encoded by one gene (41, 122, 
210) while the γ-subunit is encoded on a separate gene (40, 148, 189, 211).  rTFIIA was 
produced from bacteria separately over expressing TFIIAαβ and TFIIAγ, purified under 
denaturing conditions, and renatured either separately or in a mixture of equal molar amounts.  
Gel mobility shift assays were conducted on a DNA fragment containing a TATA box to assess 
the activity of reconstituted rTFIIA (Fig. 13).  TBP alone failed to bind the probe, as did either 
TFIIAαβ or TFIIAαβγ.  TBP plus TFIIAαβ also failed to bind the probe, due to the absence of 
the γ-subunit, which is required for the stabilized binding of TBP to TATA boxes.  However, 
TFIIAαβγ stabilized the binding of TBP to DNA forming the previously observed “DA” 
complex (40, 148, 189, 211).  An antibody specific to the γ-subunit was able to induce a 
supershift, suggesting the presence of TFIIA in this complex and confirming the successful 
reconstitution of TFIIA activity.   
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Figure 13.  Reconstitution of TFIIA activity using recombinant proteins.   
TFIIAαβ and TFIIAγ were expressed in E. coli, purified under denaturing conditions and renatured separately or 
together.  rTFIIA activity was assessed via gel mobility shift analysis with αβ or αβ + γ, and TBP on the TATA 
motif of the ICP4 promoter.  Only TFIIA αβ + γ was able to stabilize binding of TBP to the TATA box and be 
supershifted by a TFIIA gamma specific antibody suggesting successful reconstitution of TFIIA activity. 
 
Recombinant TFIIA was then compared to the A and Superose 12 fraction for the ability 
support ICP4-activated transcription of the tk and gC promoters in vitro (Fig. 14A).  Again, ICP4 
efficiently activated the gC promoter independent to a TFIIA-containing preparation (Fig. 14A), 
and was unable to efficiently activate the tk promoter in the absence of a TFIIA preparation (Fig. 
14A).  However, rTFIIA, like the A and Superose 12 fractions, restored the ability of ICP4 to 
efficiently activate the tk promoter.  These data support the interpretation that TFIIA is not 
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 essential for activation of the late gC promoter but is required for efficient activation of the early 
tk promoter.  
 
Figure 14.  Ability of rTFIIA to enhance ICP4 activation of an early (tk), a late (gC), and an initiator-mutated 
late (gC8) promoter in vitro.   
A.  The indicated amounts (in microliters) of Superose 12 human TFIIA and rTFIIA were assayed for the ability to 
support ICP4 activation of the tk, gC, and gC8 promoters in vitro.  Shown are the autoradiographic images of primer 
extension products of the in vitro transcription reactions.  B.  Quantification of in vitro transcription reactions 
conducted as described in the legend for panel A.  Additional in vitro transcription reactions were conducted 
precisely as described for panel A.  The dried gel containing the electrophoretically separated primer extension 
products was analyzed using a Storm 840 PhosphorImager.  Under each condition, the fold activation by ICP4 from 
two determinations was calculated and averaged.  Without the addition of a TFIIA-containing fraction, ICP4 
activated the tk, gC, and gC8 promoter by five-, nine-, and fourfold, respectively.  The values for fold activation 
under each of the conditions (TFIIA additions) were divided by fold activation for no addition in reactions with the 
corresponding promoter.  Shown are the ratios of fold activation for no addition (none), Superose 12 fraction 
addition (sup12), and the addition of the indicated amounts of rTFIIA. 
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True late promoters are relatively simple promoters that do not require upstream activating 
sequences for efficient expression (199, 203).  The efficient activation of the gC promoter by 
ICP4 requires only an intact TATA box and INR region.  The initiator element has shown to be 
crucial for ICP4’s ability to activate gC promoter, since mutations in the initiator reduce its 
ability to efficiently activate transcription (79, 110).  TFIID makes contact with the INR and 
ICP4 facilitates TFIID binding to promoters (25, 78).  TFIIA has previously been shown to be 
essential for activated transcription in the context of TFIID, yet as our results indicate, TFIIA is 
not essential for ICP4 to activate the gC promoter.  TFIIA has also been shown to stabilize 
TFIID binding to the TATA box.  Therefore, we reasoned that it was possible that in the absence 
of a functional INR, TFIIA might restore the ability of ICP4 to activate transcription.  To this 
end, we compared the ability of ICP4 to activate the gC promoter to that of a derivate of the gC 
promoter with a mutated INR element, gC8, in the presence and absence of TFIIA (Fig. 14A).  
gC8 has three nucleotides mutated in the initiator region and is severely compromised for ICP4 
activation (110).  In the absence of the A fraction, gC8 was minimally activated by ICP4 and 
addition of the A fraction somewhat stimulated activation.  Substitution of the A fraction with 
human or recombinant TFIIA significantly stimulated ICP4 activation, suggesting that in the 
presence of TFIIA the requirement for the INR element for activation by ICP4 is reduced. 
A quantitative representation of the effects of TFIIA on ICP4 activation of the tk, gC, and 
gC8 promoters is given in Fig. 14B.  Additional reactions were conducted as described for Fig. 
14A.  The fold activation under each condition was determined as described in the figure legend.  
Shown are the ratios for fold activation with the indicated addition relative to that with no 
addition.  Therefore, while gC was strongly activated by ICP4 without TFIIA addition (Fig. 
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 14A), the addition of TFIIA had little effect on the fold activation (Fig. 14B).  In contrast, the 
addition of the Superose 12 TFIIA preparation to reaction mixtures with the tk and gC8 
promoters resulted in 4.6- and 3.9- fold-greater activation, respectively, compared to that in 
reactions without TFIIA addition.  Similar results were obtained upon the addition of rTFIIA 
(Fig. 14B). 
 
4.4.3. Expression of TFIIA during wild-type HSV infection 
 
Because cellular gene expression is significantly changed during the course of lytic infection we 
were interested in looking at what consequences this had on the expression of components of the 
basal transcription machinery as a function of time post infection.  Microarray analysis 
conducted on mock-infected cells and cells infected with wild-type virus for 4 and 8 hours 
revealed a decrease in the abundance of the mRNA for the smallest γ-subunit of TFIIA (data not 
shown).  Northern blot analysis using 2 µg of poly(A)+ RNA from mock- and KOS- infected 
cells confirmed the decreased expression of this subunit as well as that for the other subunits of 
TFIIA.  By 8 hpi, TFIIA mRNA was undetectable (Fig. 15).  These data indicate that TFIIA 
abundance may decreases as a function of infection. 
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Figure 15.  TFIIA mRNa levels as a function of infection.   
Poly(A)+ RNA (2 ug) isolated from KOS-infected (multiplicity of infection =10) or mock-infected HEL cells at 4 
and 8 hpi was subjected to Northern blot analysis probing for all the TFIIA subunit mRNAs. 
 
 
4.5. DISCUSSION 
 
Unlike many cellular activators, ICP4 does not have a requirement for specific DNA binding 
sites for activation and therefore it can activate transcription from a variety of promoters.  
Looking at two distinct promoters, the tk promoter and the gC promoters, we found different 
cellular requirements for ICP4-activated transcription.  Specifically, the GTF TFIIA was 
required for efficient ICP4 activation of the tk promoter but was not essential for activation of 
the late gC promoter.  These results indicate that ICP4 has some different requirements for 
components of the general transcription machinery based on the promoter and possibly on the 
HSV kinetic class of promoter.  
These results suggest that the composition or the assembly of ICP4-activated 
transcription complexes on the two promoters is different.  In the assembly of Pol II transcription 
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 complexes, TFIID is the first factor recruited to the TATA box and is required for subsequent 
complex assembly (18, 194, 213).  By participating in the complex, TFIIA helps stabilize 
binding of TFIID to the TATA box (35, 97, 115, 123).  TFIIA and the TAFs present in TFIID are 
also required for activated transcription by such activators as VP16, Sp1, CCAAT binding factor 
and the Epstein-Barr virus transactivator Zta (119, 147, 211).  In addition, many of these 
activators have been shown to interact with TFIIA, TFIID, or both, and these interactions 
correlate with the ability to stabilize or enhance TFIID-TFIIA-promoter complex assembly and 
promote transcription (111, 118, 148).  In contrast, ICP4 will activate the gC promoter in the 
absence of TFIIA (25, 79) (Fig. 14B).  It has also been shown to interact with TFIID (25), 
enhance the binding of TFIID to TATA boxes, and promote preinitiation complex (PIC) 
formation in the absence of TFIIA (78).  Therefore, it is likely that ICP4 operationally substitutes 
for TFIIA in that it independently performs a function normally associated with TFIIA, allowing 
for efficient activation of the gC promoter.   
TFIIA, however, is clear required for efficient activation of the tk promoter.  One 
difference between the tk and gC promoters is the existence of an INR element located at the 
start site of gC transcription.  Core promoters contain a TBP sequence, located 25 to 30 bp 
upstream of the transcription start site, and some have an initiator element (INR) encompassing 
the start site.  The presence of an INR in addition to a TATA box can serve to enhance the 
strength of that promoter (55, 120).  For promoters that lack a TATA consensus, the initiator 
element can direct accurate transcription initiation by itself or in conjunction with other promoter 
elements (125, 177, 178).  TAF150, TAF250 and TBP found in TFIID have been shown to stably 
interact with the INR element and are sufficient for INR activity (26, 195).  ICP4 has been 
shown to bind TFIID through TAF250 and has been shown to stabilize TFIID interaction to the 
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 core promoter (25).  The late gC promoter contains both a TATA box and an INR region.  
Mutations in the initiator element diminish the ability of ICP4 to activate transcription (79, 110).  
We show here that in the context of an intact INR, ICP4 does not require TFIIA for activated 
transcription (Fig. 14).  This suggests that ICP4 sufficiently stabilizes TFIID through the INR 
element without the activities of TFIIA.  In the presence of a mutated INR, ICP4 alone is no 
longer able to stabilize TFIID interaction and requires the additional activities of TFIIA.   In the 
presence of TFIIA, ICP4 overcomes the requirement for an intact INR and in conjunction with 
TFIIA stabilizes TFIID-promoter interactions, thereby promoting activation by ICP4.  Although 
ICP4 interacts with TFIID through TAF250 and TFIIA interacts with TFIID through TBP it is 
not currently known whether ICP4 directly interacts with TFIIA.  It will be interesting to 
determine whether ICP4 participates in tripartite complexes with TFIIA and TFIID (or TBP) on 
early and late promoters and to determine the contribution of the INR element on these potential 
interactions. 
 
4.5.1. Biological significance of the differential requirement for TFIIA in the activation 
of early and late genes 
 
HSV infection results in dramatic cellular changes, occurring at the levels of mRNA, protein 
abundance, and post-translational modifications.  At late times of infection, the expression of 
cellular proteins is greatly perturbed suggesting that the composition and/or abundance of 
components of the Pol II transcriptional machinery may also be significantly altered.  Northern 
blot analysis indicated that the expression of the smallest subunit of TFIIA decreased as a 
function of infection (Fig. 15).  The viral functions that downregulate TFIIA expression are not 
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 currently known.  However, this result suggests that TFIIA may not be available for transcription 
late after infection.  This of course would also depend on the stability and activity of the pre-
existing three-peptide subunits of TFIIA. 
While INR elements have been found on most late promoters, they have not been found or 
described on early promoters.  Therefore, it is possible that a reduction in TFIIA abundance may 
be one of the mechanisms functioning in the switch from early to late transcription.  It is likely 
that this mechanism is not the only one functioning in this switch.  Sp1, which is clearly involved 
in the transcription of early genes and immediate-early genes, is phosphorylated about the time 
early genes are shut off.  This phosphorylated form of Sp1 is less active in transcription than 
uninfected cell Sp1 (109).  Viral DNA replication is also involved in the switch from early to late 
gene transcription.   In addition, TFIIA is required for activated transcription by VP16, Sp1 and 
the CCAAT binding protein.  Since these activators are involved in immediate-early and early 
gene transcription, a reduction in TFIIA activity would also reduce the effect of these activators 
on immediate-early and early transcription.  
 ICP4 is a large complex molecule with many possible features and functions that have yet 
to be recognized that allow it to activate transcription from a variety of promoters.  In the context 
of lytic infection, it would follow that if components of the transcription machinery were 
changing as a function of infection, ICP4 might activate transcription by a variety of mechanisms 
involving different contacts with different cellular transcription factors.  As presented here, 
TFIIA is required for efficient activation of early promoters but not late promoters.  The 
decreased abundance of TFIIA late in infection may contribute to the switch from early to late 
transcription. 
73 
  
 
 
5. STABILIZED BINDING OF TBP TO THE TATA BOX OF HSV-1 EARLY (tk) 
AND LATE (gC) PROMOTERS BY TFIIA AND ICP4 
 
 
5.1. ABSTRACT 
 
Although most activators require all the components of the basal transcription machinery to 
activate transcription, we have recently shown through an in vitro transcription system that ICP4 
has a differential requirement for the general transcription factor TFIIA.  TFIIA is dispensable 
for ICP4-activation of a late promoter (gC) but is required for the efficient activation of an early 
promoter (tk).  An intact INR element is required for proficient ICP4-activation of the late 
promoter in the absence of TFIIA.  In the presence of INR-mutated late promoter, ICP4 requires 
the additional activities of TFIIA to activate transcription suggesting that in the presence of 
TFIIA, ICP4 can overcome the requirement of an intact INR on late promoters.  Because TFIIA 
is known to stabilize the binding of both TBP or TFIID to the TATA box of core promoters and 
ICP4 has been shown to interact with TFIID, we tested the ability of ICP4 to stabilize the 
binding of either TBP or TFIID to the TATA box of representative early, late, and INR-mutated 
late promoters (tk, gC, and gC8, respectively).  Utilizing DNase I footprinting analysis, we found 
that ICP4 was able to facilitate TFIIA stabilized binding of TBP to the TATA box of the early tk 
promoter.  ICP4 and ICP4-derivatives, n208 but not X25, could stabilize the binding of TBP to 
both the wild-type and INR-mutated gC promoters.  When TFIID was substituted for TBP, ICP4 
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 could stabilize the binding of TFIID to the TATA box of the wild-type gC promoter.  ICP4, 
however, could not effectively stabilize TFIID binding to the TATA box of the INR-mutated late 
promoter.  The additional activities of TFIIA were required to stabilize the binding of TFIID to 
the INR-mutated late promoter.  Collectively, these data suggest that TFIIA may be dispensable 
for ICP4-activation of the wild-type late promoter because ICP4 can substitute for TFIIA’s 
ability to stabilize the binding of TFIID to the TATA box.  In the absence of a functional INR, 
ICP4 can no longer stabilize TFIID binding to the TATA box of the late promoter and requires 
the additional activities of TFIIA.   The stabilized binding of TFIID by TFIIA may in turn allow 
ICP4 to more efficiently activate transcription from non-INR containing promoters.  
 
 
5.2. INTRODUCTION 
 
The expression of Herpes simplex virus type 1 genes relies on the functions of the host cellular 
transcription machinery (6, 36).  Initiation of transcription is a major control point of viral as 
well as cellular gene expression and requires the proper assembly of the general transcription 
factors TFIIA, -B, -D, -E, -F, -H and RNA Pol II into preinitiation complexes (PIC) on core 
promoter elements (reviewed in 124).  PIC formation begins with the binding of the general 
transcription factor TFIID, a multisubunit complex composed of the TATA binding protein 
(TBP) in association with 10 to 14 TBP-associated factors, known as TAFs (reviewed in 5).  The 
TBP subunit of TFIID recognizes and binds to the TATA box present on core promoters.  
Although TBP is sufficient for basal transcription initiation, activated transcription requires the 
TBP-associated factors of TFIID (19).  Many cellular as well as viral activators have been shown 
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 to interact with the general transcription machinery through interactions with TAFs (21, 73, 77).  
TAFs also play an important role in recognition of non-TATA box core promoter elements, such 
as the INR, that may be present in place of or in addition to a TATA box on core promoters (105, 
106).  TAF250, TAF150 and TBP of TFIID are sufficient for INR element recognition and 
function.  TFIID binding to the TATA box and/or to the INR is stabilized by TFIIA and TFIIB.  
Whereas TFIIB is essential for basal transcription directed by either TBP or TFIID, TFIIA is 
dispensable for TBP-directed basal transcription.  Although basal transcription with TBP does 
not require the general transcription factor TFIIA, TFIIA can stabilize TBP’s interaction with the 
TATA box (18, 35, 97, 115, 123).  In the absence of TFIIA, however, activated transcription 
does not occur suggesting that although it may be dispensable for basal transcription with TBP, 
TFIIA plays an important role in transcription initiation and activation with TFIID (40, 111, 122, 
147, 189, 211).  The formation of a TFIID-TFIIA-TFIIB-DNA complex allows the subsequent 
recruitment of the rest of the general transcription factors, TFIIE, -F, -H, and RNA Pol II, that 
are recruited individually or as preformed complexes to the core promoter completing PIC 
formation and thus ready to initiate transcription. 
Transcriptional activators physically promote the formation of transcription preinitation 
complexes by facilitating the recruitment of one or more GTFs to target promoters.  Similar to 
the many transactivators that exert their strength through the cellular transcription machinery, the 
HSV major transcriptional regulatory protein, ICP4, has been shown to interact with components 
of the general transcription machinery to either activate or repress transcription (25, 79-81, 113, 
181).  One of the first gene products produced during infection, the 175 kDa protein ICP4 (153), 
localizes as a 350 kDa homodimer (135) in discrete foci in the nuclei of infected cells where both 
viral transcription and replication are thought to originate (60, 61).  ICP4 functions as the major 
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 transcriptional activator of early and late genes (45, 58, 72, 74, 142) making it essential for lytic 
infection (44, 51, 106, 202).  
ICP4 as a transcriptional activator contains many conserved regions that include a DNA 
binding, a nuclear localization, and both N- and C-terminal transactivation regions (47, 151, 
175).  Although the DNA binding domain is essential to its function as an activator, the 
operationally defined DNA-binding domain alone is not sufficient for transcriptional induction, 
as demonstrated by the isolation of ICP4 deletion mutants that bind to ICP4 consensus sites but 
do not activate transcription.  ICP4 does not require any single or collection of ICP4 specific 
binding sites and no ICP4 sequence specific binding sites responsible for activation have been 
identified on early and late promoters (29, 54, 56, 180).  ICP4 can bind DNA that has a fairly 
degenerate consensus sequence and has been shown to activate promoters in vitro without ICP4 
sequence specific DNA binding sites (79).   
The N- and C- terminal transactivation domains are essential to ICP4’s ability to activate 
transcription.  ICP4 has been shown to interact with the general transcription factors TFIIB 
through its N-terminal transactivation domain (181) and with TFIID through its C- terminal 
transactivation domain (25).  Like many cellular activators, ICP4 cannot activate transcription 
when TBP is substituted for TFIID (79).  Activation of transcription by ICP4 requires the TAFs 
present in TFIID.  ICP4’s interaction with TAF250 of TFIID through its C-terminal 
transactivation domain serves to increase the rate of transcription preinitiation complex 
formation on viral early and late promoters (78).  ICP4 expressing viruses lacking either the N- 
or C-terminal transactivation regions express reduced levels of viral early and late genes and are 
impaired for viral growth in culture (47, 173).   
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 During lytic infection viral gene expression proceeds from the expression of immediate-
early to early to late genes (92).  The expression of viral genes, which occurs in these three 
highly regulated phases, are mediated in part by the structural differences within the promoter 
architectures of each of the three classes of genes (200, 216).  Since viral genes are transcribed 
by the cellular transcription machinery, the one element that most all HSV-1 promoters contain 
in common is a TATA box.  Aside from a TATA box, however, the promoters of each of the 
three classes of genes are distinct, with a trending decrease in promoter complexity from 
immediate-early to early to late genes (reviewed in 199, 203).  Immediate-early promoters, in 
addition to containing numerous cellular cis-activating sequences upstream of the TATA box, 
are the only promoters that contain viral specific activating sequences.  Early promoters lack any 
viral specific sequences but still retain binding sites for cellular specific factors, such as Sp1 and 
CTF.  These cellular activators have been shown to work in concert with ICP4 and the cellular 
transcription machinery to activate transcription of early genes.  Late promoters significantly 
differ from IE and E promoters in that late promoters lack any influential upstream cis-acting 
sequences that are binding sites for either cellular or viral specific factors (64, 83, 91, 94, 100).  
For true late promoters, the sequences downstream from the TATA box are important for late 
gene regulation (79, 82, 83, 94, 185).  The INR element, identified on many late promoters, is 
one such region downstream from the TATA box.  INR elements, which overlap the initiation 
start site, are common to many cellular core promoters and can promote transcription initiation in 
the absence of a TATA box or can synergize the effects of a TATA box (reviewed in 177).  
These elements are specifically recognized by components of the general transcription factor 
TFIID (105, 106).  The INR in addition to a TATA box has been shown to be essential for ICP4 
activation of late promoters and, unlike early promoters, ICP4 can activate transcription from 
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 these promoters with a relatively simple set of general transcription factors (79).  Mutations in 
the INR element diminish the ability of ICP4 to activate transcription from these promoters 
(110). 
Because early and late promoters are structurally distinct yet still activated by ICP4, the 
cellular requirements for the activation of early and late genes by ICP4 may be different.  Indeed 
in an in vitro reconstituted transcription system, ICP4 cannot activate transcription of a 
representative early promoter with a relatively simplified set of general transcription factors.  
Other cellular factors in addition to ICP4, such as Sp1, are required for activation of early genes.  
ICP4, on the other hand, can efficiently activate transcription of a representative late promoter 
with a simple set of general transcription factors dependent on the presence of a functional INR 
(79).  In addition, we have recently reported that there is a differential requirement for the 
general transcription factor TFIIA for ICP4-activation of early versus late genes in vitro (212).  
TFIIA is required for efficient ICP4-activation of the early tk promoter.  Surprisingly however, 
TFIIA is dispensable for ICP4-activation of the late gC promoter.  Dispensability of TFIIA for 
ICP4 activation of the late promoter requires an intact INR.  In the absence of a functional INR, 
the additional activities of TFIIA allow ICP4 to overcome the necessity for an INR element.  In 
addition TFIIA expression decreases as a function of wild-type infection.  Thus TFIIA, which is 
suggested to be required for all activated transcription, is not essential for ICP4-activation 
depending on promoter context.  Moreover, the decreased expression of TFIIA and its 
dispensability for late gene activation by ICP4 suggests that functions of ICP4 can substitute for 
the activities specified by TFIIA in a promoter dependent manner.  In an effort to delineate the 
basis for TFIIA’s dispensability for ICP4-activation of late genes, the binding properties of ICP4, 
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 TFIIA, and TBP or TFIID on the tk, gC and INR-mutated gC promoters were analyzed by 
DNase I footprinting analysis.  
 
  
5.3. MATERIALS AND METHODS 
 
5.3.1. Proteins 
 
Purified recombinant TFIIA and TBP have been previously described (212).  ICP4, n208 and 
X25 were purified respectively from wild-type (KOS), n208 and X25 producing virus-infected 
Vero cells as previously described (25).  TFIID was immunoaffinity purified from α3 HeLa cells 
containing a hemagglutinin (HS) epitope-tagged TBP as previously described (25) and analyzed 
via silver stain analysis and Western blots using antibodies directed against TAF250, TAF150, 
TAF55, and TBP.  The relative amounts of TBP in immunoaffinity-purified TFIID were 
determined by Western blot analysis using an antibody directed against TBP and comparing the 
resulting signals to those from known amounts of purified rTBP.  For all analyses, 2 ng of rTBP, 
12 ng of rTFIIA and 250 pg TBP-equivalent TFIID were used unless otherwise noted. 
 
5.3.2. DNase I footprinting analysis 
 
The SgrA1 – NheI fragments of the pgCLS1 and pgCLS8 plasmids (110) representing the wild-
type gC and INR-mutated gC promoters, respectively, and the EcoR1 – Bgl II fragment of the 
pLSWT plasmid (95) representing the tk promoter, were end-labeled on the coding strand using 
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 polynucleotide kinase and  γ32 P ATP.  The labeled fragment was then purified and quantified.  
One nanogram of an end-labeled probe (3 X 104 to 6 X 104 cpm/ng) and the indicated mixture of 
proteins were incubated for 30 mins at 30oC in a 30 ul reaction buffer consisting of 12.5 mM 
HEPES (pH 7.8), 60 mM KCl, 12.5% glycerol, 5 mM MgCl2, 0.5 mg/ml of bovine serum 
albumin, 20 mM B-mercaptoethanol, and 0.006 ug/ul of poly (dG) . poly(gC).  Following 
incubation, 4 ul of 10X DNaseI reaction buffer (50 mM CaCl2, 100 mM MgCl2) was added to 
each reaction and incubated for an additional 10 min at 30oC.  1 ul of DNase I (0.125 U) was 
added to each reaction at room temperature for 1 min and stopped by the addition of 40 ul of stop 
buffer (0.2 M NaCl, 0.02 M EDTA, 1% w/v sodium dodecyl sulfate, 20 mg/ml tRNA, 1 mg/ml 
proteinase K).  Reactions were then incubated at 37oC for 10 mins following phenol and 
chloroform extraction, and ethanol precipitation.  Pellets were resuspended in 95% formamide 
and run out on denaturing 6% gels for gC promoter analysis or 8% denaturing gels for analysis 
of the tk promoter.  Gels were dried and exposed to Amersham Hyperfilm. 
 
 
5.4. RESULTS 
 
5.4.1. ICP4, as well as TFIIA, stabilizes the binding of TBP to the TATA box of the 
wild-type late (gC) and INR-mutated late (gC8) promoters 
 
TFIIA has been shown to stabilize binding of TBP to the TATA box present on cellular 
promoters (18, 35, 97, 115, 123).  To determine whether ICP4 could also stabilize binding of 
TBP to the TATA box, DNase I footprinting analysis was performed on the viral late gC 
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 promoter.  DNase I footprinting analysis is a highly sensitive method utilized to determine the 
exact binding location of a given protein or group of proteins on a DNA fragment containing 
sequence specific binding sites.  This method has been previously utilized to show TFIIA 
induced the stabilized binding of TBP to the TATA box (97, 147, 211).  The late gC promoter, 
which is highly activated by ICP4, is a simple promoter that contains only two influential 
specific DNA binding sites, the TATA box and an INR element (79, 110).  The TATA box is 
recognized by TBP, whereas the INR element is recognized by the TBP-associated factors, 
TAF250 and TAF150, of TFIID (195).  When individual proteins TBP or TFIIA were tested for 
the ability to bind to the promoter region of the gC promoter, neither TBP nor TFIIA alone 
bound to the TATA box or any regions surrounding the TATA box (Fig. 16A, lanes 2 and 3).  
On the other hand, ICP4 alone at concentrations of 10 but not 5 ng, bound to regions 
surrounding, but not directly at the TATA box as DNase I sensitive sites were present at the 
TATA box (Fig. 16A, lanes 4 and 5).  TFIIA, as previously observed for cellular promoters, 
stabilized the binding of TBP to the TATA box of the gC promoter, evidenced by DNase I 
protection of the TATA region (Fig. 16A, lane 6).  ICP4 also stabilized the binding of TBP to the 
TATA box in the absence of TFIIA suggesting that ICP4 alone is sufficient to stabilize TBP 
binding to the TATA box (Fig. 16A, lane 7 and 8).  ICP4, however, had no effect on binding of 
TFIIA to the gC promoter, as reactions containing TFIIA and ICP4 look similar to ICP4 alone 
(Fig. 16A, compare lanes 9, 10 with lanes 4, 5).  These results suggest that ICP4 can substitute 
for TFIIA in promoting the stabilized binding of TBP to the TATA box of the gC promoter. 
 Mutations in the INR significantly reduce the ability of ICP4 to activate transcription (79, 
110).  The INR-mutated late gC (gC8) promoter is essentially composed of only a TATA box 
since three nucleotides have been mutated within the INR element (110) rendering this promoter 
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 less responsive to ICP4 activation in the absence of TFIIA (212).  When this promoter was 
substituted for with wild-type gC promoter, TFIIA stabilized the binding of TBP to the TATA 
box of this promoter (Fig. 16B, lane 18).  Similar to that seen for the wild-type promoter, ICP4, 
like TFIIA, was also able to stabilize binding of TBP to the TATA box (Fig. 16B lane 19 and 20) 
while having no effect on binding of TFIIA to the promoter (Fig. 16B, lanes 21, 21 compared to 
lanes 16 and 17).  This suggests that ICP4 can substitute for TFIIA in stabilizing the binding of 
TBP to the TATA box of the late promoter regardless of the presence or absence of a functional 
INR element. 
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Figure 16. Stabilized TBP-TATA interactions on the wild-type and INR-mutated late gC promoters by either 
ICP4 or TFIIA.   
DNase I footprinting analysis was conducted on (A) the wild-type or (B) the INR-mutated late promoter using TBP, 
TFIIA and ICP4.  Neither TBP nor TFIIA bound to either promoter alone (lanes 2, 3 and lanes 14, 15, respectively).  
ICP4 alone bound regions outside of the TATA box of both promoters at 10 but not 5 ng (lanes 4, 5 and lanes 16, 
17).  TFIIA (lanes 6 and 18) as well as ICP4 (lanes 7, 8 and lanes 19, 20) stabilized the binding of TBP to the TATA 
box of either promoter, while ICP4 had no effect on the binding of TFIIA (lanes 9, 10 and lanes 21, 22).  The 
presence of ICP4 in addition to TFIIA had no net effect on TBP-TATA interactions (lanes 11, 12 and lanes 23, 24). 
 
To determine the lowest concentration of ICP4 able to stabilize the binding of TBP to the 
TATA box of either the wild-type or the INR-mutated late promoter, without binding to either 
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 promoter itself, varying concentrations of ICP4 were used in the presence or absence of TBP 
(Fig. 17B).  ICP4 at 2.5 ng retained the capacity to efficiently stabilize the binding of TBP to the 
TATA box of both promoters.  The ability of ICP4 at 2.5 ng to stabilize TBP binding to the 
TATA box was comparable to TFIIA’s ability to stabilize the binding of TBP.  ICP4 even at 1 ng 
was able to stabilize the binding of TBP to the TATA box.  Thus, ICP4 at concentrations as low 
as 1 ng could stabilize the binding of TBP to the TATA box without binding to regions 
surrounding the TATA box of either the wild-type or INR-mutated late promoter.  These results 
also further support that ICP4 does not require the presence of a functional INR to stabilize the 
binding of TBP to the TATA box of the late promoter. 
 
5.4.2. Regions of ICP4 required to stabilize the binding of TBP to the TATA box of the 
wild-type and INR-mutated late promoters 
 
ICP4 is a large structurally complex molecule that contains discrete domains conserved across 
many ICP4 orthologs.  Two ICP4 domains mapped out in Fig. 17A that have been shown to be 
essential for the ability of ICP4 to activate transcription are the N- and C-terminal transactivation 
domains (175, 176).  n208 is a 774 amino-acid derivative of 1,298 amino-acid ICP4 that lacks 
the C-terminal transactivation domain (47).  This polypeptide still retains a number of physical 
and functional properties characteristic of the intact molecule such as the N-terminal 
transactivation domain, the DNA binding and dimerization domain, and the nuclear localization 
signal (175).  Despite the presence of these functional domains, n208 producing viruses are 
defective for viral growth due to a block at the stage subsequent to viral early gene expression 
(47).  n208 lacks viral DNA synthesis and is impaired for the expression of true late genes, 
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 which may be a sole consequence of the deficiency of DNA synthesis.  Despite the inability of 
this virus to replicate, n208 molecules can localize to the nucleus of infected cells, bind ICP4 
specific DNA binding sites, and retains the capacity to activate a number of viral early and late 
genes.   
Because n208 retains the ability to bind DNA, autoregulate, and activate a number of 
viral genes (46, 47), the regions still present in this molecule may contribute to the ability of 
ICP4 to stabilize binding of TBP to the TATA box.  When substituted for full-length ICP4, n208 
was able to efficiently stabilize the binding of TBP to the TATA box, at concentrations as low as 
1 ng (Fig. 17C).  Stabilized binding of TBP to the TATA box by n208 at 1 ng was comparable to 
TFIIA stabilized binding of TBP.  These results suggest that the regions outside of the C-
terminal transactivation domain of ICP4 are required to stabilize binding of TBP to the TATA 
box.  In addition no differences were evident in the ability of n208 to stabilize TBP binding to 
either the wild-type or INR-mutated late promoter, suggesting again that the INR is not required 
for ICP4 to direct or facilitate binding of TBP to the TATA box.  
 X25, diagramed in Fig. 17A, is similar to n208 in that it lacks the C-terminal 
transactivation domain (residues 775 through 1298) but, in addition, also lacks the N-terminal 
transactivation domain (residues 30 through 274).  Removal of both amino acids 30 to 275 and 
775 through 1298 results in a mutant protein that still retains sequences sufficient for site-
specific DNA binding and multimerization, yet lacks the ability to activate transcription in 
transient assays (172).  To determine if regions specified in the N-terminal transactivation 
domain were important for stabilized binding of TBP in the background of a C-terminal 
transactivation domain mutation, X25 was substituted for ICP4.  X25 at varying concentrations 
was unable to stabilize binding of TBP to the TATA box of either the wild-type or INR-mutated 
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 gC promoter (Fig. 17D).  This suggests that regions specified within the N-terminal 
transactivation domain of ICP4 are necessary for both binding to the gC promoter alone and 
stabilizing the binding of TBP to the TATA box.  These data also suggest that the DNA binding 
activity of ICP4 is not sufficient to facilitate TBP binding.  
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Figure 17. Regions of ICP4 required for stabilized binding of TBP to the TATA box of the wild-type and 
INR-mutated late gC promoters.   
A. Domain map of ICP4 and properties of mutants relative to wild-type ICP4.  The important regions of ICP4 are 
indicated by boxes with their amino acid location indicated on the scale directly above the boxes.  The primary 
structure of each of the mutant molecules relative to the wt protein is indicated.  Transactivation in vivo was 
determined by transient transfection assays and/or the transcription rates of selected viral genes in the context of 
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 viral infection.  DNA binding was determined by electrophoretic mobility shift assay.  This summary was derived 
from several previous studies.  B. wild-type ICP4 alone stabilized TBP-TATA interaction on either the wild-type or 
INR-mutated late promoter.  ICP4 alone at 10 but not 2.5 ng bound to regions outside of the TATA box on both the 
wild-type and INR mutated late promoters.  ICP4 at 2.5 and 1 ng, which did not bind either promoter alone, was still 
able to stabilize TBP-TATA interactions, comparable to TFIIA.  C.  An ICP4 derivate lacking the C-terminal 
transactivation domain, n208 maintained the ability to bind to regions outside of the TATA box of both promoters.  
It was also able to stabilize TBP-TATA interactions similar to full-length ICP4 suggesting that the C-terminal 
transactivtion domain of ICP4 is not required to stabilize binding of TBP to the TATA box.  D.  An ICP4 derivative 
lacking both the N and C-terminal transactivation domain, X25, could not bind to either promoter alone at varying 
concentrations nor was it able to stabilize the binding of TBP to the TATA box of either promoter suggesting that 
the N-terminal transactivation domain of ICP4 is necessary to stabilize TBP-TATA interactions on either the wild-
type or INR-mutated late promoter. 
 
5.4.3. ICP4 stabilizes the binding of TFIID to the TATA box of the wild-type but not the 
INR-mutated late promoter 
 
ICP4 alone is sufficient to stabilize binding of TBP to the TATA box to both the wild-type and 
INR-mutated late promoter (Fig 16).  Because ICP4 and n208, but not X25, have been shown to 
interact with TBP in solution (25) it is not surprising that both ICP4 and n208, but not X25, are 
able to stabilize binding of TBP to the TATA box of the wild-type and INR-mutated late 
promoters.  However, in the context of cells, TBP is usually found associated in multi-subunit 
complexes such as TFIID.  To determine if ICP4 was also able to stabilize the binding of TFIID 
to the TATA box of the wild-type late promoter, TFIID was substituted for TBP.  The individual 
proteins TBP, TFIIA, TFIID, and X25 at 10 ng were unable to bind to the gC promoter alone 
(Fig. 18, lanes 3 - 6).  TFIIA stabilized the binding of either TFIID or TBP to the gC TATA box 
(Fig. 18, lanes 9 and 10).  X25, unable to stabilize the binding of TBP to the TATA box (Fig. 
17D), also did not promote TFIID-TATA interactions (Fig. 18, lanes 11 and 14).  Full-length 
ICP4, observed to stabilize the binding of TBP, also stabilized the binding of TFIID to the TATA 
box of the gC promoter (Fig. 18, lanes 12, 13 and 15, 16, respectively).  This occurred regardless 
of whether ICP4 bound directly to regions on this promoter as ICP4, unbound at 5 ng (Fig. 18, 
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 lane 8), was able to stabilize binding of either TBP or TFIID (Fig. 18, lanes 13 and 16) as 
effectively as ICP4 bound at 10 ng  (Fig. 18, lane 8, 12, and 15).  ICP4 stabilized binding of 
TFIID appeared similar to the ICP4 stabilized binding of TBP (Fig. 18, compare lanes 15 and 16 
with lanes 12 and 13) and this was comparable to TFIIA stabilized binding of TFIID and TBP 
(Fig. 18, compare lanes 12, 13, 15 and 16 with lanes 9 and 10).  ICP4, however, had no effect on 
TFIIA, as TFIIA in the presence of ICP4 looked similar to ICP4 binding alone (Fig. 18, compare 
lanes 17 – 19 with lanes 6 – 8).  These results suggest that ICP4 alone can substitute for TFIIA in 
the ability to stabilize binding of TFIID to the wild-type gC promoter.  
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Figure 18. ICP4 alone can stabilize TFIID-TATA interactions on the wild-type INR-containing late promoter.   
Affinity purified TFIID was unable to stably bind to the TATA box alone (lane 4).  TFIIA was required to stabilize 
the binding of either TBP or TFIID to the TATA box of the wild-type promoter (lanes 9 and 10).  In addition, ICP4 
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 alone, but not X25, could also stabilize the binding of either TBP (lanes 11-13) or TFIID (lanes 14-16) to the 
promoter at either 10 or 5 ng.  ICP4 had no effect on binding of TFIIA (lanes 17-20), as binding appeared similar to 
ICP4 alone (lanes 6-8).  TFIIA in addition to ICP4 had no net effect on either TBP-TATA (lanes 22 and 23) or 
TFIID-TATA (lanes 25 and 26) interactions.  However, TFIIA did promote stabilized binding of either TBP (lane 
21) or TFIID (lane 24) in the presence of the ICP4 derivative, X25. 
 
 
Figure 16B and 17B suggest that ICP4 stabilizes the binding of TBP to the TATA box in 
the absence of a functional INR.  However, ICP4’s ability to stabilize the binding of TFIID to the 
TATA box may differ and may require the presence of a functional INR element.  To determine 
whether an intact INR element was required for the ability of ICP4 to stabilize the binding of 
TFIID to the TATA, the INR-mutated late gC8 promoter was analyzed (Fig. 19).  Similar to the 
wild-type promoter, neither TBP, TFIIA, affinity-purified TFIID, or the ICP4-derivate X25, 
alone were able to bind to the INR-mutated late promoter (Fig. 19A, lane 5; B, lane 6).  ICP4 
alone at both concentrations of 10 and 5 ng bound to the gC8 promoter (Fig. 19A, lanes 6 and 7).   
Due to this, a lower concentration of ICP4 at 2.5 ng that did not bind the gC8 promoter was also 
analyzed (Fig. 19B, lane 8).  As observed with the wild-type late promoter, TFIIA stabilized 
binding of either TBP or TFIID to the TATA box of the INR-mutated late promoter (Fig. 19A, 
lanes 8 and 9, 7B, lanes 9 and 10).  X25 again had no effect on the ability of either TBP or TFIID 
to bind the TATA box (Fig. 19A, lanes 10 and 13; 7B, lanes 11 and 14).  Although ICP4 could 
stabilize TBP binding to the TATA box of this INR-mutated promoter at concentrations ranging 
from 10 to 2.5 ng (Fig. 19A, lanes 11 and 12; B. lanes 12 and 13), ICP4 at both high and low 
concentrations, was unable to efficiently stabilize the binding of TFIID to the TATA box of this 
late promoter (Fig. 19A, lanes 14 and 15; B. lanes 15 and 16).  TFIID in the presence of ICP4 
appeared similar to ICP4 alone indicating that ICP4 could not efficiently stabilize the binding of 
TFIID to the TATA box of an INR deficient late promoter (Fig. 19B, compare lanes 15 and 16 
with lanes 7 and 8).  The additional activities of TFIIA were required to stabilize TFIID-TATA 
94 
 interactions (Fig. 19B, lanes 24 and 25).  These results suggest that although ICP4 can stabilize 
the binding of TBP to a promoter consisting of only a TATA box, ICP4 alone is not sufficient to 
stabilize the binding of TFIID to a promoter containing only a TATA box.  Stabilized binding of 
TFIID to a promoter containing only a TATA box required the activities of TFIIA.  Thus in the 
absence of a functional INR element on a late promoter, ICP4 cannot substitute for TFIIA to 
stabilize TFIID binding to the TATA box. 
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Figure 19. ICP4 does not efficiently stabilize binding of TFIID to the TATA box of the INR-mutated late 
promoter in the absence of TFIIA.   
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 Footprinting analysis of the INR-mutated late promoter was conducted with 10 and 5 ng of ICP4 (A.) and with 5 and 
2.5 ng of ICP4 (B.).  Due to the ability of ICP4 to bind to INR-mutated late promoter regions alone at both 10 and 5 
ng (A, lanes 6 and 7) a lower concentration of ICP4 at 2.5 ng that did not bind alone (B, lane 8) was also analyzed.   
Individual proteins, rTBP, rTFIIA or affinity purified TFIID were unable to bind to the INR-mutated late promoter 
alone (A, lanes 2 – 4 or B, lanes 3 – 5).  TFIIA stabilized the binding of either TBP or TFIID to the TATA box (A, 
lanes 8 and 9 and B, lanes 9 and 10).  Although, ICP4 alone stabilized the binding of TBP to the TATA box (A, 
lanes 11 and 12, B, lanes 12 and 13), ICP4 at concentrations of 10, 5 and 2.5 ng did not efficiently stabilize TFIID-
TATA box interactions on the INR-mutated late promoter (A, lanes 14 and 15 and B, lanes 15 and 16).  TFIIA was 
required to effectively stabilize the binding of TFIID to the TATA box of this promoter in the presence of ICP4 
(lanes 24 and 25).  In addition the ICP4 mutant, X25, had no effect on binding of either TBP or TFIID (A. lanes 11 
and 14).  
 
5.4.4. ICP4 facilitates TFIIA in stabilizing the binding of TBP to the early promoter 
TATA box 
 
Unlike the gC promoter which contains a fairly strong TATA box with a sequence TATTAA, the 
tk promoter has a lower affinity TATA consensus sequence (34).  Whereas 3 ng of TBP alone 
could bind the gC TATA box (data not shown), the same concentration of TBP alone could not 
bind to the TATA box of the tk promoter.  Increasing concentrations of TBP showed that 40 ng 
of TBP alone was required to bind to the tk TATA box (Fig. 20).  TFIIA reduced the required 
concentration to 20 ng.  Addition of ICP4 to TFIIA further reduced the amount of TBP required 
to bind the tk promoter to 10 ng.  Thus higher concentrations of TBP are required to bind to the 
TATA box of the tk promoter and TFIIA significantly reduced the amount required.  ICP4 
further reduced the amount of TBP required, probably by facilitating the ability of TFIIA to 
stabilize the binding of TBP to the TATA box. 
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Figure 20. ICP4 facilitates the ability of TFIIA to stabilize the binding of TBP to the TATA box of the tk 
promoter.   
Whereas 3 ng of TBP alone bound to the gC promoter (data not shown), 40 ng of TBP alone was required to bind to 
the TATA box of the early tk promoter.  TFIIA reduced the amount of TBP required for binding to the TATA box to 
20 ng and addition of ICP4 further reduced the amount of TBP to 10 ng. 
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 5.5. DISCUSSION 
 
In this study the binding properties of TFIIA, ICP4 and TBP/TFIID were examined on 
representative early, late, and INR-mutated late promoters.  Our results indicate that ICP4 could 
substitute for TFIIA in stabilizing the binding of TBP to both the wild-type and INR-mutated late 
promoters.  For the early promoter, ICP4 facilitated TFIIA’s ability to stabilize the binding of 
TBP to the TATA box.  When the TBP-containing complex TFIID was substituted for TBP, 
ICP4 was only able to stabilize TFIID binding to the TATA box of the wild-type late promoter, 
not to the INR-mutated late promoter.  Stabilized binding of TFIID to this promoter required 
TFIIA.  These results suggest that the efficient ICP4-activation of the wild-type gC promoter in 
the absence of TFIIA may be explained by the ability of ICP4 to substitute for TFIIA in 
stabilizing the binding of TFIID to the TATA box in the presence of a functional INR element.  
In the absence of a functional INR, ICP4’s ability to activate transcription is severely 
compromised due to the inability of ICP4 to efficiently stabilize TFIID binding.  TFIIA is 
required to stabilize TFIID-TATA box interactions on this INR-mutated promoter alleviating 
ICP4’s requirement for an intact INR, allowing ICP4 to more effectively activate transcription 
from this promoter.  Thus, ICP4 can substitute for TFIIA in stabilizing the binding of TFIID to a 
late promoter containing a functional INR element but cannot substitute for TFIIA in stabilizing 
the binding of TFIID in the absence of a functional INR element. 
 
5.5.1. The regions of ICP4 required for the stabilized binding of TBP to the TATA box 
 
The observation that ICP4 and n208 directly stabilize the binding of TBP to the TATA box of 
the gC promoter is not unexpected since both forms of ICP4 have been shown to interact with 
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 TBP in solution (25).   The ability of n208, which lacks amino acids beyond 778, to both interact 
with TBP in solution and to stabilize binding of TBP to the TATA box of the late promoter (Fig. 
17C), suggests that the C-terminal transactivation domain is dispensable for TBP interaction and 
TATA box stabilization.  The inability of X25, which lacks amino acids 30 – 274 in addition to 
amino acids beyond 778, to stabilize TBP-TATA or TFIID-TATA interaction strongly suggests 
that regions specified within amino acids 30 – 274, which include the N-terminal transactivation 
domain, are necessary for ICP4’s ability to stabilize TBP-TATA interactions and may be 
necessary for direct interaction with TBP.  Moreover, this suggest that the DNA binding domain 
alone, which is still intact in X25, is not sufficient to stabilize TBP binding to the TATA box. 
 Although both ICP4 and n208 are able to interact with TBP in solution (25) and can 
efficiently stabilize binding of TBP to the TATA box (Fig. 17B and C), neither one of these 
molecules are able to activate transcription with TBP (79).  Activated transcription by ICP4 
requires the TBP-associated factors of TFIID.  ICP4’s C-terminal domain has been shown to 
interact with TAF250 of TFIID to promote transcription preinitiation complex formation (25).  
Mutants that lack the C-terminal transactivation domain, such as n208 and X25, do not interact 
with TFIID in solution (25).  The fact that n208 interacts with TBP in solution but not with 
TFIID implies that TBP is inaccessible in the context of TFIID in solution. Interestingly 
however, n208, but not X25, is still able to recruit and stabilize the binding of TFIID to an 
immobilized gC promoter template suggesting that in the presence of a TATA box, n208 can still 
stabilize TFIID binding (78).  Results presented here support the idea that the N-terminal 
transactivation domain of ICP4 is required for this effect.  n208 bound to promoter DNA, may 
encourage a rate limiting conformational change during weak TFIID-TATA interactions, 
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 exposing TBP and allowing for interactions with the N-terminal domain of n208 which in turn 
may serve to stabilize TFIID binding to the TATA box. 
 Activated transcription not only requires the TAFs of TFIID, it also requires the general 
transcription factor TFIIA (40, 111, 122, 147, 189).  Although TFIIA has a weak stimulatory 
effect on basal transcription lacking exogenous activators and is dispensable for TBP-directed 
basal transcription in purified systems in vitro, TFIIA is essential for activator-mediated 
transcription.  In the absence of TFIIA, many activators lose the ability to activate transcription 
(40, 118, 148, 211).  Activators interact directly with TFIIA to mediate stabilized interaction 
with TBP and the preinitiation complex.  TFIIA, as well as TAFs, directly interact with and 
stabilize the binding of TBP within TFIID to the TATA box of core promoters (18, 35, 97, 123).  
Dynamic interplay exists between TFIIA and TAFs that regulate the binding of TFIID to 
promoter DNA.  TFIIA mediates an activator-induced conformational change in the transcription 
factor TFIID that significantly alters the interaction of TAFs with promoter DNA (55, 147).  The 
amino-terminal domain of TAF250 contains a negative regulatory element that inhibits TBP-
TATA complex formation, demonstrating that at least one TAF can preclude the interaction of 
TBP with the TATA box.  TFIIA, as a positive acting general factor, has been shown to 
competitively derepresses the inhibitory effect of TAF250 by destabilizing the interactions 
between TAF250 and TBP (55, 147).  Thus it is of interest that ICP4 interacts with TAF250 of 
TFIID and that it can substitute for TFIIA in stabilizing the binding of TFIID to the TATA box 
of an INR containing promoter.  ICP4 may function in a manner analogous to TFIIA in that it 
may alleviate the inhibitory effects of TAF250.  The regions of TAF250 that interact with ICP4 
have yet to be determined.  However, it is plausible that ICP4, through its C-terminal 
transactivation domain, can competitively interact with TAF250’s N-terminal negative 
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 regulatory domain to destabilize its interaction with TBP.  This may in turn allow the N-terminal 
region of ICP4 to interact with TBP to stabilize its interaction with the TATA box in the context 
of TFIID.  
 
5.5.2. Late promoter requirements for TFIID stabilized binding to the TATA box by 
ICP4 
 
Previous analysis of the promoter requirements for ICP4-activation of viral late genes has 
determined that the INR element, present on most true late promoters, is the only other element 
required in addition to the TATA box for efficient ICP4-activation, suggesting that late 
promoters are quite simple and unusual in nature since these are the only two promoter elements 
required for activation.  Mutations within the INR element of a representative late promoter 
severely compromise the ability of ICP4 to activate transcription from this gene both in vitro and 
in vivo (79, 110).  Like cellular promoters, immediate-early and early promoters, in addition to 
core promoter elements, contain numerous cis-acting sequences for transactivators that work 
synergistically to recruit and stabilize the transcription machinery through interactions with 
different components of the general transcription factors.  However, ICP4 alone can activate 
transcription with a relatively simple set of general transcription factors without the requirement 
of other cellular or viral specific activators in the presence of only a TATA box and a functional 
INR element (79).  In addition, the general transcription factor TFIIA is not required for ICP4 
activation of a late promoter containing an INR and a TATA box (212).  This is quite intriguing 
since TFIIA has previously been shown to play an unusually important role in INR-mediated 
transcription (87, 126, 189).  TFIIA has been shown to selectively enhance TFIID transcription 
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 from a promoter that contains both a TATA box and an INR (55).  TFIID alone has been shown 
to have similar affinities for TATA and TATA-INR promoters.  TFIIA strongly enhances TFIID 
binding to a TATA-INR promoter while having little effect on binding to a TATA box only 
promoter.  This suggests that TFIIA-induced conformational changes are essential for the 
sequence-specific TFIID interaction with the INR.  ICP4 may be functioning in a similar manner 
to TFIIA.  Through protein-protein interactions and potential conformational changes that occur 
within both ICP4 and TFIID, ICP4 may relieve the inhibitory effect of TAF250 and induce 
interactions of TAFs with the INR in a manner similar to TFIIA.  
ICP4’s interaction with TFIID has been shown to be critical for ICP4 activation late in 
infection.  The ability of ICP4 to interact with TFIIA has not been tested.  Due to the declined 
expression of all three subunits of TFIIA during infection and its dispensability for late gene 
activation, it is likely that if ICP4 and TFIIA do interact, interactions at late times of gene 
expression are not essential.  Since the promoter architecture for early and late genes differs, the 
interaction of ICP4 with TFIIA may be promoter dependent.  ICP4 may interact with TFIIA 
early during infection, on early gene promoters that require TFIIA for efficient expression.  Late 
in infection when the expression of TFIIA is declining, ICP4 may perform some of the functions 
intrinsic to TFIIA and TFIIA is not required for efficient late gene expression.   
In the context of HSV infection, TFIIA is present early during infection and is required 
for activation of early genes.  ICP4 in cooperation other cellular activators that require TFIIA, 
work together to recruit and promote stabilized binding of TFIID to the TATA box of early 
promoters.  As infection proceeds, TFIIA expression decreases, coincident with its dispensability 
for INR-containing late gene expression as ICP4 can substitute for TFIIA in stabilizing the 
binding of TFIID to the TATA box, as well as induce interactions of TAFs with the INR.  This 
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 study clarifies one of the many viral mechanisms that exist for the attenuation of early gene 
expression while allowing succession of late gene expression. 
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6. SUMMARY OF THESIS 
 
 
Although HSV genes, like cellular genes, rely on the functions of the host cellular transcription 
machinery for expression (6, 36), we hypothesized that infection also impacted the expression of 
components that make up the cellular transcription machinery.  cDNA microarray chips 
containing all the components of the general transcription factors were constructed in-house and 
used to examine changes in the expression patterns of these components at early and late times of 
HSV infection.  While moderate changes in the mRNA abundance of some of the components of 
the general transcription factors were observed at early times post wild-type infection (4 hpi) 
these changes were more profound at late times of infection (8 hpi).  Only a small number of 
these components were observed to be upregulated during infection, such as the largest subunit 
of RNA Pol II, while a larger number of these factors were observed to be downregulated during 
infection, such as the smaller subunits of RNA pol II, TFIIA and TAF55.  The HSV mechanisms 
existing early during infection that contribute to the shutoff of cellular genes are also likely to 
contribute to the disrupted expression of components of the cellular transcription machinery.  
Such mechanisms include early translation disruption by polyribosome dispersal and mRNA 
destabilization induced by the viral specific factor vhs (reviewed in 179), inhibition of host 
cellular splicing by the IE protein ICP27 (reviewed in 170), and viral induced nuclear 
reorganizations by such viral factors as the IE protein ICP0 (reviewed in 57, 84).  Because the 
normal composition of these factors is essential to the transcription of cellular genes, changes 
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 observed in the expression of these factors would certainly contribute to the downregulation of 
cellular gene expression.  
Although alterations in the normal composition of the general transcription machinery 
during infection may disrupt cellular gene expression, disruption of the transcription machinery 
would also have a large impact on viral gene expression.  Immediate-early (IE) and early (E) 
promoters contain binding sites for cellular activators that work in concert with viral activators, 
such as VP16 and ICP4, that promote expression of these genes (reviewed in 199, 203).  Many of 
these viral and cellular activators interact with and recruit components of the basal transcription 
machinery to IE and E promoters making these interactions essential to activated  transcription.  
Because these genes rely on cellular transactivators that require the normal composition of the 
cellular transcription machinery for expression, upsetting the normal balance of the cellular 
transcription machinery early during infection would not be highly beneficial to their expression. 
Most of the observed changes in the expression of general transcription machinery occur later in 
infection (beyond 4 hpi) when early and late genes are being expressed, suggesting that if any 
components of the general transcription machinery were altered during infection it would largely 
impact E and L gene expression.  Coincidently, beyond 4 hpi early gene expression is attenuated 
signifying that changes in the general transcription machinery may contribute to the declined 
expression of early genes.  However, viral late genes are efficiently expressed late in infection, 
suggesting that viral transcriptional regulatory mechanisms must exist that cooperate with these 
changes to allow for the continued high-level expression of late genes.  Rather than containing 
cis-acting sequences that are the binding site for cellular activator, late promoters have 
sequences, such as the INR and downstream activating sequences (reviewed in 199, 203), that 
are recognized by components of the general transcription factors (26, 82, 106, 107, 154).  
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 Recruitment of the GTFs and the activation of late genes is primarily accomplished through the 
viral transactivator ICP4.  Because late genes do not require cellular activators that rely on the 
normal composition of the general transcription machinery, late genes may still be efficiently 
activated by ICP4 with an altered set of transcription factors.  Unlike most transcription factors, 
ICP4 does not require DNA specific binding sites on early and late promoters to activate 
transcription.  Given that ICP4 is a fairly large protein that can potentially interact with the 
general transcription machinery in different ways, ICP4 may have differential requirements for 
the general transcription machinery depending on promoter context.  Thus although many of the 
components of the general transcription machinery are differentially expressed late in infection 
trending toward declining expression, ICP4 may substitute, or may not require some of the 
functions of the general transcription factors that are altered or are no longer available at the time 
late genes are expressed. 
Through microarray and Northern blot analysis, the expression of the largest subunit of 
the 12-subunit RNA Pol II enzyme was observed to increase while the smaller subunits were 
observed to decrease as a function of wild-type infection.  Additionally, the largest subunit, 
which contains the carboxy-terminal domain essential to transcription initiation and elongation, 
is aberrantly phosphorylated during infection (164).  A combination of these changes must have 
some effect on cellular and/or viral gene expression. It would be of interest to compare the 
protein ratios of the smallest subunits of RNA Pol II as well as the largest subunit of RNA Pol II 
and its phosphorylation pattern, from wild-type infected and uninfected cells at various times of 
infection to determine any differences in the protein composition of Pol II during infection.  
Purifying and comparing the activities of infected and uninfected Pol II in reconstituted 
transcription on cellular and viral early and late promoters in the presence and absence of ICP4 
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 to determine any differences in ICP4-mediated activation would also be a future worthwhile 
endeavor.   Perhaps infected aberrantly phosphorylated Pol II works with ICP4 to initiate 
transcription from selective promoters in part mediating class-specific differences in promoter 
activation.   
Another factor to further examine is TAF55, a component of the general transcription 
factor TFIID.  Both microarray and northern blot analysis suggested that the expression of 
TAF55 was decreased during infection.  With the newly defined function of TAF55 to interact 
with and inhibit TAF250-dependent transcription (70), it would be of interest to determine if the 
decreased expression of TAF55 during infection affects TAF250-dependent viral promoter 
activity.  Given that late but not early promotes contain an INR element that relies on TAF250 
for function, the presence of TAF55 at early times of infection could be hypothesized to block 
TAF250-dependent late gene expression early during infection while having no effect on 
TAF250-independent early gene expression.  Late in infection, the decreased abundance of 
TAF55 may lift the block in TAF250 activity resulting in an increase in the expression TAF250 
dependent late promoters.  This may be a mechanism that prevents the expression of late genes 
during early times of infection.   
One observed microarray change that we have correlated with in vitro biochemical 
analysis was the decreased expression of the general transcription factor TFIIA.  All three 
subunits of the TFIIA complex were observed to be downregulated at late times of wild-type 
infection through both microarray and northern blot analysis.  Reconstituted transcription 
analysis on representative early and late promoters showed that while TFIIA was essential for 
efficient ICP4-activation of the early tk promoter, it was not required for ICP4-activation of the 
late gC promoter.  Dispensability of TFIIA for ICP4-activation of the late promoter required an 
109 
 intact INR.  From previous studies we showed that mutations within the INR of the gC promoter 
severely compromised the ability of ICP4 to activate transcription from this promoter (110).  
However, here we show that the additionally activities of TFIIA allow ICP4 to overcome the 
requirement for a functional INR to efficiently activate transcription from an INR-mutated late 
gC promoter. 
Early promoters, which contain upstream activating sequences that are binding sites for 
cellular activators, require TFIIA in addition to ICP4 to activate transcription.  Late in infection, 
however, TFIIA expression is decreased.  This may compromise early gene expression because, 
cellular activators in conjunction with ICP4, can no longer function in the absence of TFIIA to 
activate early genes.  Thus the decreased availability of TFIIA late in infection may contribute to 
early gene attenuation.  Late genes that contain an intact INR do not require TFIIA for ICP4-
activation and therefore the decreased expression of TFIIA would not impact late gene 
expression.  This suggests a mechanism for the switch from early to late gene expression.   
TFIIA is known to stabilize the binding of both TBP and TFIID to the TATA box on core 
promoters (35, 97, 111, 115, 160, 210).  TFIIA has been termed a co-activator of transcription 
because although it stabilizes the binding of TBP to the TATA box, TFIIA is not required for 
TBP-mediated transcription.  The TBP-associated factors of the general transcription factor 
TFIID are also not required for basal transcription and have also been termed co-activators of 
transcription.  Yet in the context of eukaryotic cells with the exception of yeast, TBP is rarely 
found in free form.  TBP is usually associated in multi-subunit complexes, such as general 
transcription factor TFIID (reviewed in 77).  For TFIID-mediated basal and activated 
transcription, TFIIA is required (35, 40, 66, 111, 118, 119, 122, 189, 211).  TFIIA is thought to 
counteract the repressive effects of TAF250 of TFIID.  TAF250 inhibits the binding activities of 
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 TBP through interactions with the DNA binding surface of TBP.  TFIIA interacts with repressive 
domain of TAF250 relieving its interaction with TBP, allowing TBP to bind to the TATA box of 
DNA (147).   
For activated transcription, both TFIIA and the TAFs of TFIID are required (reviewed in 
124, 145).  Although these factors seem to be dispensable for basal transcription, they play very 
important roles in activated transcription since most cellular as well as viral activators interact 
with TFIIA and TAFs.  ICP4 requires the TAFs of TFIID to activate transcription (79).  
However, ICP4 seems to have a differential requirement for TFIIA depending on the promoter 
context.  This is not completely unusual giving that ICP4 can activate transcription of randomly 
different genes.  Unlike other activators that bind to promoter specific sequences to activate 
transcription, ICP4 does not require binding to a DNA-specific sequence to activate 
transcription.  This is beneficial to viral gene expression, because this allows ICP4 to activate 
transcription of vastly different viral promoters.  Perhaps differential interactions of ICP4 with 
the cellular transcription machinery and/or alteration of this machinery may also allow for 
regulation of ICP4-activated transcription of different classes of genes at different points during 
infection.  
What causes TFIIA to be dispensable for ICP4 activation in the presence of an INR 
element in addition to a TATA box?   When we examined the binding properties of ICP4, TFIIA 
and TBP/TFIID on the tk, gC and INR-mutated gC promoter, footprinting analysis showed that 
ICP4 like TFIIA stabilized the binding of TBP on the TATA box of the gC and INR-mutated gC 
promoters.  An ICP4-derivative n208, which lacked the C-terminal activation domain, was also 
able to stabilize TBP to the TATA box.  However, another ICP4-derivativeX25, which lacked 
both the N- and C-terminal transactivation domain, was not able to stabilize the binding of TBP 
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 to the TATA box.  The fact that n208, lacking the C-terminal domain, but not X25, lacking both 
the C- and N-terminal domains, was able to stabilize binding of TBP to the TATA box suggested 
that the N-terminal activation domain played an important role in this event.   Although ICP4’s 
ability to stabilize TBP was noteworthy, as mentioned above, ICP4 requires the activities of the 
TAFs of TFIID to activate transcription.  When TFIID was substituted for TBP, ICP4 could only 
efficiently stabilize TFIID binding to the wild-type gC promoter but not the INR-mutated gC 
promoter.  TFIIA was required to stabilize binding of TFIID to the INR-mutated gC promoter.  
These results suggest that ICP4 could substitute for TFIIA in stabilizing the binding of TBP or 
TFIID to the TATA box of the wild-type INR containing gC promoter.  However, ICP4 was 
unable to effectively stabilize the binding of TFIID to the TATA box in the absence of a 
functional INR and required the additional activities of TFIIA.     
In piecing together the data that TFIIA is required for ICP4-mediated activation of early 
genes, but late in infection TFIIA expression is downregulated and is dispensable for ICP4-
mediated activation of INR-containing but not INR-mutated late genes, with the result that ICP4 
can substitute for TFIIA in stabilizing the binding TFIID to the wild-type but not INR-mutated 
late promoter a picture emerges of the possible mechanism by which ICP4 might activate 
transcription of INR-containing late genes, later in infection without the requirement for TFIIA.  
ICP4 may function in a manner similar to TFIIA only on INR-containing promoters.  TFIIA 
normally relieves TAF250’s inhibitory effect on TBP by displacing TAF250’s repressive domain 
from the DNA-binding surface of TBP (147).  TFIIA also directly interacts with TBP within 
TFIID to stabilize its binding to the TATA box.  Additionally, TFIIA strongly enhances TFIID 
binding to a TATA-INR promoter (55) and a TAF250-TAF150-TBP complex is known to be 
sufficient for INR activity (105, 107, 195).  TFIIA can bind to and alter the organization of TAFs 
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 in the TFIID complex and this reorganization, particularly through TAF250 interaction can 
enhance the ability of TFIID to interact with the INR.  ICP4 interacts with TAF250 through its 
C-terminal activation domain (25).  It is possible that the C-terminal domain of ICP4 also 
interacts with the repressive domain of TAF250 to alleviate its inhibitory effect on TBP.  The 
exposure of TBP may then allow the N-terminal domain of ICP4 to interact with TBP and 
stabilize its binding to the TATA box. ICP4 induced conformational changes of TAF250 may in 
turn enhance and stabilize TFIID’s interaction with the INR on late promoters leading to efficient 
activation of late genes in the absence of TFIIA.  ICP4 induced conformational changes of 
TAF250 may not be sufficient enough to stabilize TFIID binding in the absence of a functional 
INR shifting the equilibrium of TAF250 back toward its TBP-inhibitory state. Future 
experiments should be aimed at determine which regions of TAF250 and TBP interact with 
ICP4.  Regardless, this results in the inability of ICP4 to efficiently activate transcription of an 
INR-mutated late promoter.  The addition activities of TFIIA are required to secure TFIID 
binding to the TATA box of the INR-mutated late promoter.  This suggests why TFIIA allows 
ICP4 to overcome the requirement of a functional-INR on late promoters.   
In summary we have shown that the expression of many components of the general 
transcription machinery are dysregulated during infection.  One of the observed changes that 
correlated with transcription analysis was the decreased expression of all three subunits of the 
TFIIA complex.  Although the decreased expression of TFIIA during infection most likely 
contributes to the suppression of cellular genes, TFIIA also impacts the expression of viral genes.  
We showed that TFIIA was required for the efficient ICP4-mediated activation of a 
representative early gene but that it was dispensable for the activation of a representative INR-
containing late gene.  Early promoters do not contain INR elements.  These promoters do 
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 however contain binding sites for cellular activators that work with ICP4 to activate 
transcription.  Cellular activators require TFIIA for function.  In addition, ICP4 in the absence of 
an INR also requires the TFIIA for function because as our data suggests, ICP4 cannot 
effectively stabilize the binding of TFIID to a TATA box alone.  This suggests that ICP4 
activates transcription of early genes in a distinctly different manner from the way it activates 
INR-containing late genes.  We further showed that ICP4 did not require TFIIA for the efficient 
activation of an INR-containing late gene because ICP4 could substitute for TFIIA in stabilizing 
the binding of TFIID to this promoter.  In contrast, ICP4 required the additional activities of 
TFIIA to activate transcription from an INR-mutated late promoter because it could not 
effectively substitute for TFIIA in stabilizing TFIID binding to a TATA box in the absence of an 
INR.  This correlates with previous observations that ICP4 activates early and late genes by 
different mechanisms.  Putting all of this together in the context of cells, at early times of 
infection TFIIA is available and is required for the expression of early genes.  Because these 
promoters contain cis-acting sequences but do not contain any INR elements, ICP4 as well as 
cellular activators function through TFIIA to stabilize TFIID binding to the TATA box to 
activate transcription.  Late in infection the TFIIA expression is decreased and may no longer be 
available for ICP4 and other cellular activators to activate transcription of early genes, leading to 
early gene attenuation.  The decreased expression of TFIIA does not effect late gene expression 
because for late promoters that contain an INR, TFIIA is no longer required for ICP4-activation.  
ICP4 can efficiently stabilize TFIID binding to the TATA box in the presence of an INR, which 
serves to activate transcription of these genes.  Collectively all this data provide evidence that the 
decreased expression of TFIIA during infection is one mechanism that contributes to the shutoff 
of early gene expression allowing the shift to late gene expression.  
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